A YEAR OF RESILIENCE

Annual Report and Accounts 2019–20 WELCOME TO WHY WE NEED TO BREAST CANCER ACT NOW: NOW’S ANNUAL REPORT AND ACCOUNTS 2019–20 ONE IN SEVEN WOMEN THERE ARE AN ESTIMATED This report covers the period WILL FACE IT IN THEIR 35,000 PEOPLE LIVING from 1 August 2019 to 31 July LIFETIME WITH INCURABLE 2020. SECONDARY BREAST CANCER IN THE UK

THIS YEAR, AROUND AROUND 11,500 WOMEN Inside 55,000 WOMEN AND BREAST CANCER AND 85 MEN IN THE UK 370 MEN WILL BE DIE FROM BREAST CANCER Trustees’ Annual Report TOLD THEY HAVE IS THE MOST COMMON EVERY YEAR 4 Message from the Chief Executive and Chair BREAST CANCER CANCER IN WOMEN IN THE UK 8 About Breast Cancer Now 9 Strategic report 2019/20 THAT’S THAT’S SOMEONE A DEATH 48 Financial review EVERY 10 EVERY 45 51 Governance, structure and management MINUTES MINUTES 59 Statement of Trustees’ Responsibilities

Financial statements 60 Independent Auditors’ Report

63 Financial statements and notes

Other information 86 Legal and administrative AN ESTIMATED 600,000 PEOPLE IN THE UK ARE LIVING WITH OR BEYOND BREAST CANCER details 87 Thank you

2 Annual Report and Accounts 2019–20 3 Message from the Chief Executive and Chair Message from the Chief Executive and Chair

A YEAR OF RESILIENCE

Delyth Morgan, Jill Thompson, Chief Executive Chair of Trustees

Our lives and the lives of those at the very furloughed around 70% of our workforce. No heart of our charity – people affected by decision was more difficult than changing breast cancer – became filled with doubt, the size and structure of the charity, which uncertainty and worry. As we worked resulted in 45 much-valued colleagues quickly to provide clarity, reassurance and subsequently leaving the organisation. We support in a rapidly evolving situation, by would like to thank all of them, and all the speaking with patients we heard hundreds colleagues still with us, for their dedicated of stories of the severe impact that the service and professionalism in such a tough Our Chief Executive, Delyth Through our life-changing care and support coronavirus was having on the emotional period. services and expert patient and health wellbeing of so many people and families Morgan, and Chair, Jill information we continued to be that trusted affected by breast cancer. In these testing times, our colleagues, Thompson, present our Annual friend that people can turn to when they partners, supporters, volunteers and Report and Accounts 2019–20. need us most. At the height of the pandemic, we saw a big researchers have all rallied so that we can drop in the number of people being referred continue to provide the support for today We are delighted to share with you Breast We continued to be a vehicle for change, to see a specialist with suspected breast and hope for the future that so many people Cancer Now’s first annual report and championing the needs of those living cancer. Screening services were paused. rely on us for. accounts as a merged charity. It has not with this devastating disease to make sure Recruitment to many clinical trials was been an ordinary year. Against a backdrop they get the best possible treatment and paused. And, while many patient’s treatment Rising to the challenge of a global pandemic, over the past care. This included the launch of our new continued unchanged, other patients saw We are immensely proud that while we have financial year we’ve faced highs and lows campaign on secondary breast cancer. delays and cancellations to their treatment been unable to run our community support but, amongst it all, we have been resolute alongside changes to the support they services, our offices have been closed and and resilient in our commitment to people We continued making breakthroughs received. This caused huge levels of anxiety colleagues have adapted to working from affected by breast cancer. in the labs, committing around £11.5 – particularly for patients with incurable home, we have continued to be there for million to world-class research that secondary breast cancer and their loved people when they need us. As the coronavirus (COVID-19) arrived in will bring us closer to the day when ones. the UK we were just over halfway through everyone who develops breast cancer Our breast care nurses have been running our year. And, despite what was already a will live. We also proudly hosted the UK Amid a national lockdown, social-distancing, our Helpline and Ask Our Nurses services difficult external environment, we continued Interdisciplinary Breast Cancer Symposium shielding and widespread economic remotely for the first time – receiving more to lay the foundations of our new charity – again, emphasising the importance of uncertainty, Breast Cancer Now was deeply than 1,400 enquiries in the first month of building on the bold and ambitious step we collaboration between professionals from affected too. Many of the world-class the pandemic. Despite the ever-changing made in creating one organisation that is many disciplines in understanding the scientists and experts we fund spent 100 support needs of people affected by here for anyone affected by breast cancer. disease and finding the very best ways to days or more unable to work in their labs. breast cancer during this time, our expert prevent it, treat it and improve the lives of Our life-changing community support health and patient information has been The successful launch of our new brand those living with breast cancer. services run at NHS hospitals have been continually reviewed and has been a trusted and visual identity in October 2019 marked suspended. And much of the fundraising source for thousands of people affected by one of the first major milestones in our new Adapting to a changing world that powers our vital work was hit hard. the disease. charity’s history. We continued to make However, as we entered the Spring of 2020, strides forward in providing people affected nobody could have foreseen the challenges Never has our resilience been more With our community support services by breast cancer the support they need that lay ahead. As the coronavirus took its tested as it has been in 2020. Like many suspended, we created new, virtual services today and giving the hope for the future that grip on the UK, it quickly became the biggest organisations, we have had to make some so that we could continue providing a lifeline so many people rely on us for. crisis facing breast cancer in decades. difficult and decisive decisions. In April, we to as many people as possible. Our Moving

4 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 5 Message from the Chief Executive and Chair Message from the Chief Executive and Chair

Forward Online programme is supporting However, over the next year, we will need It’s a vision we will continue putting all our people who have had a primary breast to be more resilient than ever. We are energy into making a reality – underpinned ‘IN THE COMING cancer diagnosis and finished their hospital- predicting that our income could drop by as by our new strategy for our merged charity, based treatment in the past two years. Our much as 20% and we have been left with which we will launch in 2020-21. Living with Secondary Breast Cancer Online little choice but to cancel two research YEAR, WE WILL programme and Virtual Meetings are giving grant funding rounds in 2020 which will People affected by breast cancer remain people a safe and confidential space to potentially see us spend at least £2 million at the heart of our charity. They always CONTINUE TO still meet with others who understand and less on world-class research in 2020-21. will. We continue to be inspired and driven are also dealing with the uncertainty and forward each day by their experiences FUND THE VERY challenges that secondary breast cancer As we write this, thousands of people and we will be keeping a close eye on the brings. For many, we know these services with breast cancer are still living each day economic, political and social environment BEST RESEARCH, are not a perfect replacement for being incredibly worried not only about their so we can make the biggest impact we can able to meet and talk in person, but we will increased risk of becoming seriously ill for them. PROVIDE THE VERY continue striving to make them as valuable if they do contract COVID-19 but about as possible. the impact of the current crisis on their In the coming year, we will continue to fund BEST SUPPORT AND breast cancer treatment in the future and, the very best research, provide the very best The coronavirus may have slowed down ultimately, their survival. support and campaign for the change that CAMPAIGN FOR much of our fundraising but it did not people affected by breast cancer really need. stop us completely. In April, despite the However, there is cause for optimism. But we can’t do it without your continued London Marathon not going ahead, many The resource and effort the NHS has put support. Whether you donate, fundraise, THE CHANGE THAT of our Team Now runners, their friends, into finding ways to safely diagnose and volunteer, campaign or support us in other their families and many others took on treat cancer during the pandemic, and ways, we need you now more than ever. PEOPLE AFFECTED The 2.6 Challenge for Breast Cancer Now. the knowledge we have gained, will prove We adapted events to make them more invaluable moving forwards. Gradually, We are here for anyone affected by breast BY BREAST CANCER lockdown-friendly, including our Afternoon breast cancer services and research are cancer, the whole way through – and we Tea Moments. And we created new, socially- returning to normal. A new normal. The hope you are with us. REALLY NEED. distanced ways of fundraising like our number of referrals continues to recover hugely successful virtual Walk 300,000 every month. Breast screening has BUT WE CAN’T challenge. restarted. The number of people beginning treatment has risen. Our researchers are DO IT WITHOUT The future back in the lab. And we continue to develop By the end of the year, our income – our online support services. Delyth Morgan Jill Thompson through fundraising, charitable activities YOUR CONTINUED Chief Executive Chair of Trustees and investments was £38.4 million up from We must make sure we are well prepared £32.5 million in the previous year, reflecting for the future. The progress that we have SUPPORT.’ the first full year of our merged charity. made in breast cancer must not be allowed In such turbulent times, to maintain our to stall. We are more determined than income at this level has taken a lot of ever to change the future of breast cancer generosity, loyalty and creativity from our and make sure that by 2050 everyone who The Trustees are aware of the Charity Commission’s guidance on public benefit and supporters – and we feel privileged to have develops breast cancer lives and lives well. confirm that they have complied with the duty in section 17 of the Charities Act 2011. such an incredible network of support standing with us.

6 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 7 About Breast Cancer Now Strategic report

SUPPORT FOR TODAY, DELIVERING SUPPORT HOPE FOR THE FUTURE AND HOPE

We are Breast Cancer Now, the charity that research who is making breakthroughs We have a bold vision. That, by 2050, Throughout this report you will see how is steered by world-class research and and driving forward progress. And a everyone diagnosed with breast cancer will we are getting closer to reaching these powered by life-changing care. We’re here vehicle for change, acting now to make live and live well. To turn our vision a reality, goals, and our vision, through our strategic for anyone affected by breast cancer, the sure anyone affected by breast cancer everything we do is focussed around three objectives. These objectives guide our whole way through, providing support for gets the best possible treatment and long-term goals: day-to-day work so we can deliver people today and hope for the future. care. affected by breast cancer the support they • Pr eventing and detecting breast cancer need for today and the hope they need for We are that trusted friend that you turn to We believe that we can change the better the future. for caring support when you need it most. future of breast cancer and make sure • S aving lives from breast cancer The expert authority on breast cancer that, by 2050, everyone diagnosed with • L iving well with breast cancer the disease lives and lives well. But we need to act now.

• W e will further our understanding of why To achieve this… breast cancer develops and spreads and use our knowledge to help prevent breast • We will raise our profile as the trusted cancer developing. organisation for everyone affected by breast cancer so they get the support they • W e will improve detection and diagnosis of need and are inspired to give support to breast cancer. make positive change.

• W e will develop kinder, smarter treatments • W e will inspire more people to support us for those with primary breast cancer* and financially to allow us grow and develop as improve access to treatments for those a sustainable organisation to meet future affected. demands.

• W e will tackle secondary breast cancer • W e will establish and embed our culture - and work to improve treatments, care and shared organisational values, behaviours, services for those affected. tools and ways of working - to enable our people to work efficiently and effectively • W e will improve support for people to deliver impact for people affected by affected by breast cancer with their breast cancer. physical and mental health and their emotional wellbeing.

*Including non-invasive breast cancers.

8 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 9 Strategic report Strategic report

Strategic objective one New method to assess breast cancer risk But the research highlights that women Professor Gareth Evans and researchers shouldn’t consider gaining weight as a way from the University of Manchester have to prevent breast cancer. Putting on weight FURTHERING OUR UNDERSTANDING OF improved the way to estimate a woman’s throughout adulthood increases the risk of chances of developing breast cancer. breast cancer after the menopause, when WHY BREAST CANCER DEVELOPS AND breast cancer is most likely to develop, The improved method takes into account and higher weight also increases the risk of known breast cancer risk factors, 143 other cancers and health conditions. SPREADS AND USING OUR KNOWLEDGE genetic variations known to be linked to breast cancer and breast density. This is an TO HELP PREVENT BREAST CANCER important step forward as by improving the way to estimate each woman’s likelihood of OUR WORK IN PUBLIC DEVELOPING developing breast cancer, it could help to HEALTH AND WELLBEING offer a tailored approach to prevention and screening. Meaning women could receive Long-term goals more or less frequent screening depending Delivering community-based lifestyle on their personal risk. advice Preventing and detecting breast cancer better Saving lives from breast cancer Over the past two years, Breast Cancer Now Scientists link weight gain to a lower risk of has been working closely with the University breast cancer before the menopause of Dundee on the ActWELL trial. Running New research results published this year in four areas across Scotland – Aberdeen, have suggested women who gain weight Dundee, Edinburgh and Glasgow – the trial from early adulthood have a lower chance aimed to test how effective it is to deliver OUR WORK IN RESEARCH Dr Howell will study samples from women of developing breast cancer before the lifestyle advice, through a trained volunteer in the UK who have taken part in the menopause than women whose weight lifestyle coach, to women aged 50-70 who international trial. Ultimately, Dr Howell remains stable. have attended routine breast screening. New project Looking for new ways to hopes it will help to find the best way to prevent breast cancers caused by BRCA1 prevent breast cancer in women at very high These results suggest that levels of As part of the trial, which ended in changes risk of developing the disease. fat could be an important factor that September 2019, Breast Cancer Now One of two new research projects we have determines the likelihood of women recruited and trained 45 lifestyle coaches funded in this area of our work this year, New project Improving ways to identify getting breast cancer. Researchers, who who delivered 623 face-to-face coaching Dr Sacha Howell from the University of women at high risk of breast cancer analysed data from 17 studies across the sessions and held 1,915 support telephone Manchester is trying to understand exactly Our second new project this year is led by world including the Breast Cancer Now calls over the two years of the trial. how the drug denosumab works to reduce Dr Adam Brentnall from the Barts Cancer Generations Study, took into account a While the full impact of this type of breast cancer risk. Institute, who is looking to improve the variety of other factors that can change a community-based lifestyle intervention is models we use to identify women at high woman’s chances of developing the disease. still being assessed, we know that 3,769 Women with changes in their BRCA1 gene risk of getting breast cancer. women requested information about are at very high risk of breast cancer, with They looked at whether women had children the ActWELL trial and 560 women were 80% developing the disease in their lifetime. In this project, Dr Brentnall will improve an and when, their starting weight, and randomised to the trial with 83% continuing Currently the only option for these women existing method, that is currently used in the family history of breast cancer. They also with the trial after the initial 12 months and to prevent breast cancer is removing both of UK, by integrating the latest knowledge and considered other lifestyle influences, such 90% saying they were likely to recommend it their breasts – a double mastectomy. understanding of breast cancer so that the as smoking, level of physical activity and to others. new model can predict the risk a woman has alcohol consumption. In laboratory studies, denosumab has of getting a particular type of breast cancer. Importantly, early evaluation shows that stopped the growth of cells that breast Dr Brentnall also hopes to understand what These important findings bring us a step the volunteer lifestyle coaches themselves cancers are thought to arise from in these best helps to predict more aggressive breast closer to understanding the fundamental increased their understanding and women. This drug is about to be tested in cancers. This project could help doctors role of weight on the risk of breast cancer awareness of the link between lifestyle a large international clinical trial to see to better identify women who may be at in younger women. Understanding the behaviours and breast cancer. Over 80% whether it will reduce the number of women greater risk of getting aggressive breast biological reasons could lead to new ways to of those who volunteered now feel they with BRCA1 changes that develop breast cancer – meaning if they do get breast prevent the disease and more accurate tests are more conscious of their own personal cancer. cancer, it can be detected and treated to assess women’s chances of developing lifestyle habits and nearly half say they have earlier. breast cancer before the menopause. started seeking more information about how to change their lifestyle.

10 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 11 Strategic report Strategic report

‘I’VE BECOME CONSCIOUS OF MY OWN SEDENTARY TIME AND PORTION CONTROL.’ OUR WORK IN POLICY, INFLUENCING AND ‘IF I FELT I COULDN’T BE BOTHERED DOING A WORKOUT OR GOING OUT FOR A WALK IN THE CAMPAIGNING DRIZZLE I THOUGHT OF THE WOMEN I WAS COACHING AND WHAT I WOULD SAY TO THEM.’ Bisphosphonates This year, we continued to follow up on the availability of bisphosphonates – cheap, Now For Me widely available drugs that can help to Drinking less alcohol, maintaining a healthy reduce the risk of breast cancer spreading weight and keeping physically active can all to other parts of the body and becoming help to keep a woman’s risk of developing incurable. breast cancer as low as possible. But it is not always easy to change your behaviours Last year, our Freedom of Information and habits. request showed that 75% of hospital trusts in England were routinely offering Now For Me was developed to inspire, bisphosphonates to women that would motivate and support women aged 35-55 to benefit, with another 20% in the process move more, eat more healthily and cut back of making them available. This year, we on alcohol to help reduce their risk of breast wrote to all those trusts that were in the cancer. process of making them available to check on progress, and to those that told us they The pilot campaign, which ran from 13 were not providing bisphosphonates. January to 16 February 2020, encouraged Following our long-running campaign to women to sign-up to a programme of make bisphosphonates available, we are healthy behaviour change emails. Through encouraged to hear that 94% of hospital targeted social media marketing, the trusts are now routinely offering them with campaign reached 2.2 million women in 12 3% (just four trusts) still in the process of locations, both urban and rural, across all making them available with the remaining four nations of the UK. 3% either not yet responding or providing an unclear response. Nearly 2,500 women signed up to receive emails with alcohol (56%) being the most If given to all postmenopausal women popular lifestyle behaviour to receive with early breast cancer, bisphosphonates information about compared to diet (39%) could reduce the number of breast cancer or physical activity (5%). During the course deaths by 10%, as well as saving the NHS of the campaign, the Now For Me section millions of pounds per annual group of of the Breast Cancer Now website received patients prescribed them. Bisphosphonates 13,956 visits, with women aged 35-44 most are already available across Scotland and likely to visit that content. Wales.

12 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 13 Strategic report Strategic report

Strategic objective two Encouraging women across the UK to get in This year, our Breast Cancer Speaker the habit of regularly checking their breasts Volunteers delivered 20 breast awareness is vital because the sooner breast cancer talks across the UK. IMPROVING DETECTION AND DIAGNOSIS is diagnosed, the better the chance of OF BREAST CANCER successful treatment. Encouraging people to Touch, Look, Check OUR WORK IN PROVIDING Long-term goals There is an easy way to remember to check CARE AND SUPPORT your breasts – we call it Touch Look Check. We raise awareness of this important Preventing and detecting breast cancer better Saving lives from breast cancer message in many ways, including through The breast care nurses on our Helpline our website, social media channels, health and Ask Our Nurses service talk to people information publications, breast awareness affected by breast cancer and those who talks and corporate partnerships. are worried about the disease. Where appropriate, our nurses signpost people to Since we launched our newly rebranded relevant health and patient resources to Breast Cancer Now website in October 2019, support the information they are giving. OUR WORK IN RESEARCH The study, funded by Breast Cancer Now more than 200,000 people have visited the and other collaborators, found that the test signs and symptoms page making it one of the for levels of cancer DNA circulating in the most popular pages on the site. New project New way to detect cancer blood detected the return of the disease Several of our valued corporate partners – OUR WORK IN POLICY, cells in lymph nodes after treatment nearly 11 months before including Asda, M&S and ghd – encouraged INFLUENCING AND Karina Cox from Maidstone and Tunbridge patients developed symptoms or secondary their customers to check their breasts in the Wells NHS Trust is investigating whether tumours became visible on scans. last year, meaning we have been able to reach CAMPAIGNING a special ultrasound method can help millions more people about breast awareness specialists find out if breast cancer has The test, developed by researchers led by and the importance of early detection. spread to the lymph nodes in the armpit. Professor Nicholas Turner at the Breast Monitoring referral waiting times We have continued to monitor how long Cancer Now Toby Robins Research Centre at Our printed health information also continues people are having to wait to see a specialist Surgery to remove cancer in the breast and The Institute of Cancer Research, was found to be popular. From August 2019 to July 2020, after being referred by their GP under the at least some lymph nodes from the armpit to work in all types of breast cancer and we distributed 63,259 copies of Know your ‘two week wait’ in England. is the standard of care because we don’t could detect the early signs of the spread of breasts: a quick guide to breast awareness have accurate ways to examine the lymph the disease around the body (outside of the and 66,650 copies of Know your breasts: a NHS England had proposed to replace the nodes without removing and checking some brain). guide to breast awareness and screening. of them. Technological advances may now ‘two week wait’ with a new Faster Diagnosis offer new ways to check if breast cancer has Further research is now needed to Standard which would introduce a maximum time of 28 days from being referred by a GP spread to the lymph nodes in the armpit. understand how the test could be used in Reaching out to the community or following a positive screening result, to the clinic to help guide treatment and help As well as talking about breast checking either receiving a cancer diagnosis or cancer Karina will look at whether an ultrasound stop women dying from the disease. through our corporate partnerships and being ruled out. technique can be used in clinics to guide our own channels, it is important that a needle biopsy and check for any signs we reach out into communities too. Our We were concerned that there could be of breast cancer cells in the lymph nodes. Breast Cancer Public Health and Wellbeing OUR WORK IN PUBLIC unintended consequences to this, with If the procedure is easy to use and can Volunteers are vital in helping us to do this. women being seen less quickly over time successfully find cancer cells in the lymph HEALTH AND WELLBEING They help explain who we are in their local – particularly given that NHS England set nodes, a clinical trial will be designed to test area, champion the work we do and give the performance threshold for the new it further. If successful, it could help some informative and inspirational talks on the Standard at just 70%. We will continue breast cancer patients avoid armpit surgery. Anyone can get breast cancer. No matter risk factors and signs and symptoms of to discuss these concerns with NHS the size or shape of someone’s breasts it is breast cancer to everyone from community England, however, implementation of the Personalised blood test to detect return of important they check them regularly and groups and associations to local business Standard has now been delayed due to the breast cancer earlier see a GP as soon as possible if they notice and companies. A new study at five UK hospitals has found any changes or anything unusual. But we coronavirus. that a personalised blood test for women know that 1 in 2 women in the UK do not with early breast cancer could detect the regularly check their breasts. return of the disease earlier than hospital scans.

14 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 15 Strategic report

Referrals and the coronavirus Screening and the coronavirus During the peak of the coronavirus the In March 2020, most breast screening number of referrals for women with services across the UK were suspended due suspected breast cancer to see a specialist to the coronavirus. We have been working declined dramatically. with various stakeholders to understand when and how services can restart safely, We have taken every opportunity to with most services resuming over Summer encourage people to regularly check their 2020. As a member of the Scottish Breast breasts and contact their GP surgery if Screening Programme Board, we inputted they notice anything unusual, including into the successful restart of breast through our Chief Executive, Delyth Morgan, screening services in Scotland. appearing in an NHS England video on this issue. We have called on governments and the NHS across the UK to set out clear plans to deal with the backlog of referrals, including ensuring that the already stretched workforce has the capacity to deal with this challenge.

Major reviews of breast screening In October 2019, we responded to the publication of the year-long independent review of adult screening programmes in England, led by Professor Sir Mike Richards. We submitted evidence to the review and were pleased to see many of our comments addressed in the final set of recommendations. This included proposals to improve screening uptake, introduce clearer governance and incorporate family history screening into the Breast Screening Programme. Since publication of the review, we have been working with government bodies to understand the next steps and timelines for the implementation of this important set of recommendations.

A major review of the Breast Screening Programme in Scotland also began in November 2019. We have been inputting into the review as a member of the Independent Review Group overseeing it. The review is ongoing and scheduled to report its final recommendations by mid-2021.

16 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 17 Strategic report Strategic report

Strategic objective three Professor Awen Gallimore from the gamma delta cells in the breast, with one of University of Cardiff hopes to create a new them, called V delta 1, potentially important immunotherapy by targeting two types in breast cancer. DEVLEOPING KINDER, SMARTER of cells inside breast tumours that can stop the immune system from effectively Triple negative breast cancer patients TREATMENTS FOR THOSE WITH PRIMARY destroying breast cancer cells. with higher numbers of these cells in their tumour were more likely to survive than Professor Gallimore and her team are those with low numbers. While further BREAST CANCER AND IMPROVING ACCESS exploring how treatments, that show very research is needed, exploiting these T early promise to treat breast cancer, could cells could help boost the effectiveness of TO TREATMENTS FOR THOSE AFFECTED be combined to harness the power of the immunotherapies. immune system to treat the disease. If the combination is successful, they hope Training the immune system to spot drug- it could be further tested in clinical trials. resistant cancers Professor Gallimore and her team hope New research, partly funded by Breast Long-term goals that this research will help immunotherapy Cancer Now, has found that cancers that to become an effective treatment against became resistant to drugs by restoring the Saving lives from breast cancer Living well with breast cancer breast cancer, saving more lives. function of BRCA1 or BRCA2 genes could be vulnerable to immunotherapy. New project Directing the immune system at triple negative breast cancer Cancers with changes in BRCA genes can A type of immune cell called a gamma/delta be treated with platinum chemotherapy, T cell is of particular interest to researchers such as carboplatin, or PARP inhibitors. OUR WORK IN RESEARCH stop people dying from breast cancer by – but we need to better understand how Both treatments rely on alterations in BRCA investigating how non-cancer cells can gamma/delta T cells work. genes to work well. However, cancers can help triple negative breast cancer grow and sometimes sidestep the effects of these New project Understanding how we can survive. Dr Seth Coffelt and his PhD student will treatments through genetic changes that stop breast cancer spreading investigate the ability of this type of cell to restore the function of BRCA genes. Breast cancer stem cells are thought to Breast tumours are made up of a collection kill breast cancer cells. The results of this Scientists, led by Professor Chris Lord be responsible for some breast cancers of different types of cells. In addition to project will directly inform ongoing clinical from the Breast Cancer Now Toby Robins developing resistance to treatment and may cancer cells, other cells can ‘talk’ to cancer trials of immunotherapy. Research Centre at the Institute of cause breast cancer to spread. Dr Paloma cells and, in some cases, can help them Cancer Research, studied breast, ovarian, Garcia from the University of Birmingham grow. Dr Coffelt’s overall goal is to investigate pancreatic and prostate cancers with wants to find out more about how we can and improve immunotherapy for women altered BRCA1 or BRCA2 genes. They wanted target these cells to stop breast cancer In her other ongoing work, Professor Zanivan with triple negative breast cancer, which to understand how these cancers become spreading. discovered that a protein called PDH is can be more aggressive and currently lacks resistant to treatment by repairing the BRCA highly active in some of these cells. She now targeted treatments available for other genes. A protein called MYBL2 might be involved wants to understand how important PDH is types of breast cancer. and Dr Garcia’s team will be looking at in helping tumours grow and spread. Triple They found the repaired versions of these whether targeting the MYBL2 protein could negative breast cancer can be an aggressive Unique immune cell could help the body genes were subtly different from the work as a new treatment to stop breast form of breast cancer that can be difficult stop breast cancer same genes in healthy cells and could cancer returning, stop tumours becoming to treat, so through this research, we hope Scientists at the Francis Crick Institute lead to cancer cells being recognised by resistant to treatment and prevent the to understand if using existing therapies and the Breast Cancer Now Research Unit the body’s immune system. It means that disease from spreading around the body. to target PDH could help save the lives of at King’s College London have found a immunotherapies that take the brakes off This would help to give people with breast people with triple negative breast cancer. collection of specific immune cells in human the immune system could be effective cancer the best chance of survival. breast tissue including one type that are against these cancers. New project Developing a new thought to be linked to better survival in New project Understanding how other cells immunotherapy people with triple negative breast cancer. Researchers help ensure the best treatment can help triple negative breast cancer grow The immune system protects the body from These immune cells, called gamma/delta during the coronavirus Professor Sara Zanivan, from the Beatson infection caused by viruses and bacteria, T cells, are found in both healthy breast Breast Cancer Now researchers have Institute for Cancer Research in Glasgow, but it can also recognise and destroy cancer tissue and breast tumours. Scientists found contributed to developing a new method wants to find new therapies that could cells. that there are several different varieties of to asses which women diagnosed with

18 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 19 Strategic report Strategic report

oestrogen receptor positive (ER+) breast Breast Cancer Now helps NHS hospitals Analysis of the responses indicated that the treatment to ensure it is made available to cancer during the coronavirus pandemic gather patient and staff feedback on their impact of the coronavirus included delays patients in Scotland. need urgent surgery or chemotherapy. breast care service through surveys and and cancellations of treatment, uncertainty focus groups. The feedback gathered is around appointments and cancelled scans. We continue to be involved with several Due to the coronavirus, some cancer discussed to find practical ways of making We used the findings of the survey to raise other appraisals for new secondary breast treatments have been altered to protect meaningful improvements. Through listening concerns with the NHS and governments cancer drugs, including trastuzumab patients who may be more vulnerable to and learning from each other, patients and across the UK, including weekly calls with deruxtecan (Enhertu). the infection. Some women diagnosed with healthcare professionals work in a true NHS England and through the Scottish ER+ breast cancer have been prescribed partnership. Cancer Coalition and Welsh Cancer Alliance. This year, a number of drugs have also been hormone therapy to keep the disease under Our media work also highlighted the impact approved for early breast cancer. NICE control and delay their surgery. But for To deliver our Service Pledge we draw on that the outbreak was having on people and SMC approved pertuzumab (Perjeta) some, hormone therapy alone may not work 17 years’ experience of improving breast with breast cancer, including those with in combination with trastuzumab and well enough. cancer services across the country. To date, secondary breast cancer. chemotherapy as a new option after surgery over 120 breast services across the UK for certain patients, to help further reduce Analysing data from international trials, have worked with patients to develop their In July 2020, we launched a further online the risk of recurrence or secondary breast scientists arrived at guidance that will help local Service Pledge, delivering over 400 survey to help quantify the extent to cancer. This treatment was initially rejected doctors to know whose cancer is less likely improvements for primary and secondary which the coronavirus had impacted on for use by SMC in late 2019. We urged to respond to hormone therapy. breast cancer patients in the past five years. the treatment and care of people with the Scottish Government, SMC and the This year, we worked with five NHS hospitals breast cancer. Our survey, completed by manufacturer to work together to ensure A new drug inspired by broccoli and kale in the East of England Cancer Alliance. 2,124 people with breast cancer, built on this treatment is routinely available for NHS Scientists from the University of the work we did in March to further explore patients in Scotland. This treatment is now Manchester, led by Professor Rob Clarke, Helpline and Ask our Nurses people’s experiences. The findings from the available in Scotland. have found that a drug based on a natural The breast care nurses on our Helpline survey fed into our policy, influencing and compound found in broccoli, kale and other and Ask Our Nurses email service provide campaigning work during Breast Cancer Neratinib was approved for routine use by cruciferous vegetables could reverse or even tailored information and specialist support Awareness Month (October 2020). NICE and SMC as an additional treatment prevent breast cancer becoming resistant to to anyone affected by breast cancer or with option for certain patients with hormone hormone therapy. queries about breast health. Access to drugs positive, HER2 positive primary breast We continued our work to ensure that cancer after surgery and adjuvant treatment The new drug, SFX-01, blocks an important We give people the chance to talk openly clinically-effective drugs are approved with trastuzumab. chain of reactions in breast cancer cells. in a safe and confidential space, allowing for use on the NHS. We have inputted In future, it could be added to hormone them to feel more informed, confident into all breast cancer drug appraisals Trastuzumab emtansine (Kadcyla) was therapies to boost their effectiveness. and supported about what they are going by the National Institute for Health and also approved by NICE for routine use on Further research is now needed to through. Our nurses work to ensure that Care Excellence (NICE) and the Scottish the NHS for certain patients with HER2 determine who would benefit the most from their knowledge and information they Medicines Consortium (SMC) to ensure the positive primary breast cancer after their the new drug and to test it further in clinical provide is accurate and up-to-date. patient voice is heard. surgery. We are currently inputting into SMC trials. appraisal of this treatment. In terms of secondary breast cancer drugs, this year saw the three drugs (palbociclib, More broadly, we have been working to OUR WORK IN POLICY, ribociclib and abemaciclib) in combination influence a significant review NICE is OUR WORK IN PROVIDING INFLUENCING AND with fulvestrant made available for use on undertaking about the way it assesses CARE AND SUPPORT the NHS across the UK. drugs for use on the NHS. We are inputting CAMPAIGNING into this to ensure that it covers key areas We also undertook significant work of concern we have about the way drugs The Service Pledge for Breast Cancer to ensure an immunotherapy drug, are assessed and that assessments are fit Treatment, care and the coronavirus Our Service Pledge is a programme atezolizumab (Tecentriq), in combination for the future for the new types of breast To understand how the coronavirus was dedicated to improving breast cancer with nab-paclitaxel was approved by cancer drugs in the pipeline. affecting the treatment and care of people services. The Service Pledge brings patients, NICE for routine use on the NHS. This is a with breast cancer, we launched an online healthcare professionals and Cancer treatment for newly-diagnosed patients The NHS workforce survey in March 2020, inviting people to Alliances together to work in partnership to with triple negative locally advanced or The workforce is the backbone of the health share their experiences. The survey had design and deliver a concrete action plan of secondary breast cancer whose tumours service. But the breast cancer workforce 580 respondents who were living with and improvements, for everybody’s experience produce a marker called PD-L1. We are has been under severe pressure for many affected by breast cancer. of breast cancer. now inputting into SMC assessment of this years and this has been exacerbated as a

20 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 21 Strategic report Strategic report

result of the coronavirus and the expected backlog of appointments.

This year, we were a member of an NHS England taskforce looking at ways to improve the recruitment and retention of the cancer workforce. Our focus has been around the breast imaging and diagnostic workforce and clinical nurse specialists, including those to support people with incurable breast cancer. Our influencing work in this area continues following the publication of the NHS People Plan 2020- 21, to ensure the UK Government invests in staff, both now and in the future, that people affected by breast cancer rely on.

22 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 23 Strategic report Strategic report

Strategic objective four immune system in the lung to help tumours Cancer Research, led by Professor Spiros grow there. He will then use this knowledge Linardopoulos, have discovered that a new to make immunotherapies as effective as drug that blocks one of cancer’s escape TACKLING SECONDARY BREAST CANCER possible. routes from chemotherapy could be used to treat aggressive breast cancers. AND WORKING TO IMPROVE TREATMENTS, The lungs are one of the most common places that breast cancer can spread to. The drug, known as BOS172722, showed Recent studies have shown that certain it could reinvigorate the response to CARE AND SERVICES FOR THOSE AFFECTED immune cells, called neutrophils, can help chemotherapy in cancers that had become breast cancer to spread to the lungs. But resistant, in both cells grown in the lab neutrophils also play an important role and mice. The first clinical trial of the new in protecting us from infection. We must treatment is now underway in solid tumours understand exactly how they are involved in including triple negative breast cancers, secondary breast cancer in the lungs so that and the researchers believe it might also be we can stop them from helping cancer, but effective against other fast-growing cancers Long-term goals allow them to fight infection. including ovarian cancer. Saving lives from breast cancer Living well with breast cancer This research could help us understand Creating a LEGACY with a new blood test how the immune system lets breast cancer Following new results from the Breast spread to the lung and help us ensure Cancer Now LEGACY Study, analysing immunotherapies are given at the right time secondary breast cancer tumours and in the right combination with other donated by patients following their death, treatments, making them as effective as researchers have developed a new blood OUR WORK IN RESEARCH New project Understanding the role of possible. test that could help track the growth ARID1A gene in breast cancer spreading of multiple tumours around the body Dr Jason Carroll from the University of New project Stopping breast cancer and monitor how they are responding to New project Looking for a new way to block Cambridge will investigate what role becoming resistant to PARP inhibitors treatment. breast cancer reaching the brain a particular gene has in breast cancer Professor Kristijan Ramadan from the Breast cancer that has spread to the spreading around the body. He wants to University of Oxford is hoping to understand The new test relies on watching breast brain can be particularly hard to treat and understand if a class of drugs called BET why some breast cancers become resistant cancer’s molecular clock, identifying severely affects people’s quality of life. Dr inhibitors could be used to treat secondary to a group of drugs called PARP inhibitors. how many times breast cancer cells have Damir Varešlija, our Walk the Walk Fellow, breast cancer with changes in the ARID1A PARP inhibitors, which Breast Cancer Now multiplied. Researchers think the blood is looking at how gene switches in breast gene. scientists helped to develop, are a type of test could be used to track how secondary cancer cells might make them more likely to targeted therapy that can be used to treat tumours evolve over time and to monitor spread to the brain and hopes to find ways Up to 80% of breast cancers are oestrogen breast cancers with altered BRCA genes. But their response to a range of treatments, to stop this from happening. receptor positive (ER+) and are commonly sometimes cancer can become resistant to including chemotherapy, immunotherapy or treated with hormone therapies, such these drugs. targeted therapies, as well as radiotherapy. Dr Varešlija will study both breast tumours as tamoxifen and fulvestrant. Dr Carroll and tumours from the brain that have been believes the ARID1A gene is important to Professor Ramadan and his team have found With further development, the molecular donated by people with breast cancer. He allow these treatments to work. Changes in that a protein called SPRTN may be involved clock blood test could also be used in the will compare these samples to find out this gene may help breast cancers become in one of the ways in which this switch early detection of recurrence or spread of which gene switches might be responsible resistant to hormone therapies and spread happens and will be studying it further. By breast cancer following treatment, and may for breast cancer spreading to the brain. around the body. Understanding how ARDI1A understanding the role that SPRTN plays also be relevant for other forms of cancer. is involved in breast cancer spreading could in breast cancer’s resistance to PARP The hope is that this research could reveal open up new ways to stop it spreading or inhibitors, this research could lead to a new Arthritis drugs could help prevent breast new treatments to stop breast cancer treat it when it does. treatment to be used when PARP inhibitors cancer from spreading to the bone spreading to the brain or to treat breast no longer work. Scientists at the University of Manchester cancer if it has spread there. As treatment New project Investigating how the immune and University of Sheffield, funded by options are currently so limited, finding system is involved in breast cancer New drug could help overcome resistance in Breast Cancer Now with contributions from ways to do this could extend lives and vastly spreading to the lungs triple negative breast cancers other collaborators, found that a molecule improve the quality of life for people living Dr Leo Carlin from the Beatson Institute Scientists at the Breast Cancer Now Toby made by the bone, called IL-1β, encourages with secondary breast cancer in the brain. for Cancer Research in Glasgow wants to Robins Research Centre at The Institute of breast cancer cells to grow into tumours. understand how cancer cells manipulate the

24 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 25 Strategic report Strategic report

Existing arthritis drugs, such as anakinra, with the disease were also interviewed on We have been working with NHS England could block this action. five national broadcast outlets, including to better inform healthcare professionals BBC Radio 4 Today, ITV Lunchtime News on the signs and symptoms of secondary Arthritis drugs are known to be well- and Sky News, helping to call for changes breast cancer. tolerated and are widely used. It is to ensure everyone receives a prompt important that we fully understand their diagnosis. Treatment and support effects on breast cancer before they reach We have been talking to NHS England clinical trials for patients. But researchers Channel 5 News also aired our powerful and about how Clinical Nurse Specialists can be think such trials could start in two to three emotive campaign film. We also secured supported to develop their knowledge and years. If these drugs are proven to work in more than 35 pieces of press coverage in skills to support patients with secondary clinical trials, in the future they could be Scotland. breast cancer. used to prevent secondary breast cancer in the bone and save lives. As a result of our campaigning and open We welcomed the introduction of grants letter, meetings were held with Matt to support more nurses to become Clinical Hancock, Secretary of State for Health Nurse Specialists, as set out in the NHS OUR WORK IN POLICY, and Social Care and Jeanne Freeman, People Plan 2020-21. However, we now need INFLUENCING AND Cabinet Secretary for Health in Scotland. to see a comprehensive strategy to recruit In March 2020, accompanied by some of and train even more nurses in the future, CAMPAIGNING the incredible women from our Secondary to ensure that all patients with secondary Breast Cancer Campaign Group, we met breast cancer have access to the care they with the Cancer Minister, Jo Churchill, to need. In Breast Cancer Awareness Month (October deliver the letter and discuss some of the 2019), we launched The Unsurvivors, a bold key issues raised by the campaign. Alongside this, we have surveyed breast care new campaign calling for urgent changes Since our secondary breast cancer nurses to find out more about secondary to improve support, treatment and care for campaign launched we have made good nursing provision in hospitals across the UK those living with incurable breast cancer. progress in a number of areas: and the challenges nurses face. We will be The campaign was developed with the help using this to inform our campaigning in this of a Secondary Breast Cancer Campaign Diagnosis area. Group we established to support this work, We are working with GatewayC, a free online which was made up of 29 women from cancer education platform for healthcare Data collection across the UK, all living with incurable professionals, to develop a course to equip We have continued to push for data to breast cancer. GPs with the knowledge to more confidently be collected on the number of people spot cases of secondary breast cancer, diagnosed with secondary breast cancer Over 71,000 people backed the campaign leading to a quicker diagnosis. across the UK. Although in England it by adding their names to an open letter has been mandatory for hospital trusts to health chiefs across the UK. The letter We have called on NICE to improve its to collect data on new diagnoses of called for action to improve diagnosis and guidance for GPs on recognising and metastatic breast cancer since 2013, this access to drugs, as well as for commitments referring suspected cancers, so it includes has not routinely happened in practice. to invest in recruiting and training Clinical guidance on recognising potential cases of This information is vital to ensuring that Nurse Specialists and to undertake national secondary breast cancer. commissioners and healthcare providers audits to understand the number of have the information they need to people living with this disease and their We have had positive conversations with the effectively plan their services for people experiences. The letter also asked for Scottish Intercollegiate Guidelines Network living with the disease. Health Secretaries and Ministers to meet (SIGN) to develop guidelines for healthcare Breast Cancer Now and secondary breast professionals on secondary breast cancer. This year, alongside members of our cancer patients to discuss their experiences We have been pushing for clearer guidance Secondary Breast Cancer Campaign Group, and the issues they faced. for healthcare professionals on the need we have raised the issue of data collection to inform patients finishing treatment with policy makers across the UK and are To support the campaign’s launch, we for primary breast cancer of the signs calling for a secondary breast cancer audit released a news story about worrying delays and symptoms of a recurrence, including to be funded. to the diagnosis of secondary breast cancer secondary breast cancer. and secured coverage in seven national titles. Our spokespeople and women living

26 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 27 Strategic report Strategic report

Strategic objective five In March 2020, as a full UK lockdown was could provide a listening ear and emotional put in place, we began to hear about the support to people diagnosed with primary severe impact the coronavirus was having breast cancer who may have been feeling IMPROVING SUPPORT FOR PEOPLE on the lives and emotional wellbeing of so isolated due to impact of the coronavirus. many people and families affected by breast We also worked quickly to create online AFFECTED BY BREAST CANCER WITH THEIR cancer. versions of our Moving Forward and Living with Secondary Breast Cancer services. In the early days of the pandemic we were PHYSICAL AND MENTAL HEALTH AND THEIR almost overwhelmed by the number of Moving Forward people calling our Helpline, which we have Adjusting to life after treatment for EMOTIONAL WELLBEING run remotely for the first time, and emailing primary breast cancer can bring a mix of our specialist breast care nurses for trusted highs and lows. Our award-winning Moving information and support as they tried to Forward courses give people the chance understand how the coronavirus could to share their experiences in a supportive Long-term goals affect them or their treatment. environment, get tips from breast cancer experts and connect with others in We saw a huge surge in emails to our Ask a similar situation. Whether it’s help Living well with breast cancer Our Nurses service with questions and managing physical and emotional changes concerns about the coronavirus and breast or improving general wellbeing, people can cancer, with a 60% increase in enquiries in get the support they need to move forward March 2020 (compared to March 2019). with their life. 1,953 people attended Moving We received over 1,400 enquiries to our Forward courses across the UK, meaning Helpline and Ask Our Nurses service in total we could provide more than 23,400 hours of OUR WORK IN PROVIDING also had reduced opening hours (14 hours in the first month of the pandemic. Over support. fewer per week). 50% of enquiries to our specialist nurses CARE AND SUPPORT for support during this time were about the Moving Forward Online We understand that for some people it impact of the coronavirus. Thanks to the generous support of the can be difficult to talk to in person about players of the People’s Postcode Lottery, Helpline and Ask Our Nurses breast cancer or breast health concerns. Life-changing support services we had been developing an online service Our breast care nurses and highly trained And that some people prefer to receive Over the course of this year we have to complement our award-winning Moving staff on our free and confidential Helpline information in writing. Our confidential Ask provided life-changing support to 4,523 Forward courses. Drawing on the user are here for anyone affected by breast Our Nurses service means people can also people with primary or secondary breast research and testing we had done to date, cancer, their family and friends and email our breast care nurses for support cancer through community support services we rapidly rolled out a digital alternative, healthcare professionals. Whether someone and information. In 2019–20, we responded – including our Moving Forward courses and called Moving Forward Online. has just been diagnosed, has questions to 2,127 enquiries to our nurses (down 5.1% Living with Secondary Breast Cancer meet- about a loved one, wants to find out more on the previous year) and have seen the ups – and our Someone Like Me telephone Hosted in a private area of our online Forum, about the signs and symptoms or anything number of queries received through social and email service. and utilising existing features such a group- related to breast cancer – we are ready to media (predominantly Facebook) steadily based discussion, private messaging and provide tailored information and support increase. At a time where the need to support people video embedding, participants of the course over the phone. affected by breast cancer has never been can explore and discuss a range of topics We are always working hard to offer more greater, we had to take the difficult decision including: This year we responded to 10,838 calls on ways for people affected by breast cancer to suspend our community support services, our Helpline. While this is a 17.4% reduction to access support and information from many of which are run in partnership with • A djusting and adapting in the number of calls compared to the our breast care nurses. This year, we NHS hospitals, until at least January 2021. • A ctivity and energy previous year, in the first few months of have introduced more Instagram Live and This meant that by the end of July 2020, we • B reast and body awareness the coronavirus pandemic less people Facebook Live sessions with our nurses on a were unable to deliver more than 130 vital • N utrition and breast cancer were reporting symptoms of breast cancer, wide-range of topics from being diagnosed support events and courses. • Lymphoedema being referred to see a specialist, and with breast cancer when you have young • M enopausal symptoms many patients saw delays, cancellations children to side effects of hormone therapy To continue providing as much life-changing or changes to their appointments and to secondary breast cancer. During the support to people as possible, we adapted Each topic contains a video presented by treatment. As we adapted to running our year, we hosted 20 live broadcasts with an our Someone Like Me telephone and email an expert speaker and will links to further Helpline remotely for the first time, for four estimated combined audience of 1.6 million. service so that our trained volunteers information, as well as opportunities to weeks from mid-March 2020, the Helpline

28 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 29 Strategic report Strategic report

ask questions and share experiences with It is a private group where people can Younger Women Together covering many aspects of breast cancer others. watch videos and presentations by expert Our Younger Women Together residential and breast health. Information is written by speakers, get specialist information and events give women under the age of 45 experts, including our breast care nurses, By the end of July 2020, 342 people had share their experiences, understanding diagnosed with primary breast cancer and produced in several formats. Good signed up to access the Moving Forward and support with others dealing with the the chance to meet, talk, share and be quality health information can make people Online course. uncertainty and challenges that secondary themselves with other women in a similar feel more informed and better able to make breast cancer brings. Open 24/7, people can situation – away from the pressures of decisions about their treatment and care. ‘I THOUGHT THIS WAS AN EXCELLENT, WELL PUT access information and support on a range everyday life. We are a member of the Patient Information TOGETHER PRESENTATION WHICH OPENED UP A of topics any time that suits them, including: Forum (PIF) whose aim is to help people to LOT OF THOUGHT AVENUES FOR ME. I FEEL MORE Breast cancer is much rarer in younger find trustworthy health information. In 2019, REASSURED ABOUT MY FEELINGS AND WHAT SORT OF • S econdary breast cancer and coronavirus women and because some of the challenges we became one of the first organisations THINGS MIGHT HELP ME THROUGH.’ • E motional and psychological wellbeing younger women face are different, they to be awarded the PIF TICK as a trusted Moving Forward Online participant • M anaging side-effects of treatment can feel very isolated following a diagnosis. information creator. • A ctivity and exercise At each event women can get expert Start Moving Forward • R elaxation and mindfulness information and support around treatments, Our printed information is freely available Last year, we piloted a new service, Start relationships, diet, exercise and fertility. and used in breast care units across the Moving Forward. Following in-depth By the end of July 2020, 120 people had UK. From August 2019 to July 2020 we research into the group support needs signed up to join. This year our Younger Women together distributed 1,053,508 printed materials. of people affected by breast cancer, the events supported 130 young women with This included the following publications: courses are designed for people near ‘IT’S DEFINITELY A LIFELINE FOR INFORMATION AND primary breast cancer. Our Younger Women the end of active treatment or who have A ‘COMMUNITY’ FEELING FOR SECONDARY BREAST Together with Secondary Breast Cancer • 9 7,857 – Breast pain recently finished treatment. It consists CANCER PATIENTS WHEN SO LITTLE ELSE EXISTS.’ events also supported 54 women. • 6 6,650 – Know your breasts: a guide to of a half-day informal session with a Living with Secondary breast awareness and screening practical focus. People can meet others in Breast Cancer Online participant Becca, the breast cancer support app • 6 3,259 – Know your breasts: a quick guide a similar situation and benefit from expert Our breast cancer support app, Becca, has to breast awareness information and guidance. Someone Like Me been generously funded by the National • 4 7,192 – Exercises after breast cancer People don’t have to face breast cancer on Lottery Community Fund since December surgery This year, 93 people attended a Start Moving their own. Our Someone Like Me service 2017. In that time, the app has been • 2 9,976 – Your operation and recovery Forward course. matches people with one of over 200 downloaded over 40,000 times, taking the • 2 9,952 – Reducing the risk of support volunteers who have had a similar total number of downloads to over 46,000 lymphoedema Living with Secondary Breast Cancer diagnosis or experience of primary breast since Becca launched in May 2017. • 2 3,777 – Treating primary breast cancer Our Living with Secondary Breast Cancer cancer. Our volunteers provide support meet-ups give people the chance to meet over the phone or email, whenever it suits Working closely with our technical partners, In the last year, we had 4,326,582 unique others with a secondary diagnosis and get – because sometimes the only person who the app now provides personalised content visitors to the Information and Support the support and information they need can understand is someone who has been based on a person’s individual interactions pages of our website, which makes up 60.5% – whether that’s questions about pain there. with the topics and content on offer. This of all visitors to the Breast Cancer Now management, treatment and side effects or year, we also introduced a language switcher website. just want to talk openly about whatever’s on This year, we matched 1,288 people with option for Welsh speakers to use Becca. their mind. support partners – a 7.3% increase on last year. This new feature generated huge interest, Coronavirus Hub with support from some of our Welsh To respond to the ever-changing information This year, our meet-ups supported 717 ‘THE SUPPORT OFFERED THROUGH SOMEONE LIKE celebrity supporters including rugby icons and support needs of people affected women living with secondary breast cancer, ME HAS BEEN ABSOLUTELY INVALUABLE TO ME. I Mike Philips and Leigh Halfpenny. We also by breast cancer during the pandemic, providing more than 6,700 hours of support STARTED OFF WITH A SPECIFIC QUESTION ABOUT secured a huge amount of media coverage we developed a Coronavirus Hub on our in total. MY TREATMENT AND OPTIONS BUT SPENT JUST AS with stories on BBC One’s breakfast, website. MUCH TIME TALKING ABOUT THE EMOTIONAL AND lunchtime and evening news programmes in Living with Secondary Breast Cancer Online PRACTICAL ASPECTS OF OTHER PARTS OF CANCER Wales, BBC Cymru online, BBC Radio Wales, This provides continually updated frequently Following the successful launch of Moving TREATMENT. PARTICULARLY DURING THE COVID-19 BBC Radio Cymru and Welsh-language news asked questions and information on changes Forward Online, we quickly took the PANDEMIC, WHERE I CAN’T ACCESS THE USUAL channel Newyddion S4C. to breast clinic appointments, alongside learnings from it and applied them to launch SUPPORT SERVICES AVAILABLE TO THOSE WITH A useful blogs on dealing with isolation and an online programme for women living with CANCER DIAGNOSIS, I AM SO GRATEFUL THAT THIS Health and patient information keeping busy during lockdown. It also brings secondary breast cancer. SERVICE EXISTS AND THAT THE VOLUNTEERS GIVE We produce a wide-range of health and together other relevant support we offer, UP THEIR TIME SO GRACIOUSLY.’ patient information, in print and online, such as our Helpline, Ask Our Nurses and Someone Like Me user

30 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 31 Strategic report Strategic report

Someone Like Me services. Up to the end Cognitive behaviour therapy to cope with Now is a member of the group, which is a was established and had a public launch in of July 2020 the hub and its related pages menopause symptoms collective voice working together to better October 2020. received more than 180,000 visits. Professor Deborah Fenlon at Swansea influence health and care policy, with the University has shown that trained breast aim of improving the care and support of We published a range of personal stories care nurses can successfully deliver group the 15 million people living with long-term from women whose treatment or quality of cognitive behavioral therapy (CBT) sessions conditions. OUR WORK IN POLICY, life had been impacted by the coronavirus to help women who have had breast cancer INFLUENCING AND in different ways, which we shared through effectively manage night sweats and hot Breast Cancer Now supported the campaign our social media channels. These personal flushes. by promoting it to our supporters and CAMPAIGNING stories, together with coronavirus-related people affected by breast cancer. In information from our hub, were shared many We now know that hot flushes and night February 2020, our Twitter posts for the thousands of times and reached 1.5 million sweats can affect up to 85% of women campaign generated 12,235 impressions. Access to personalised care people on Facebook. after breast cancer treatment and The following month (March 2020), we The NHS Long Term Plan included an they tend to be more severe than the extended our reach of the campaign ambition that ‘By 2021, where appropriate We also increased our number of live symptoms experienced during natural further with Twitter content generating every person diagnosed with cancer will broadcasts on Facebook and Instagram. menopause. These symptoms can have 34,535 impressions, our real-life stories on have access to personalised care, including Moving from monthly to weekly, the a significant impact on the quality of life Facebook reaching 36,462 people and our needs assessment, a care plan and health broadcasts discussed a range of topics with the potential to affect sleep, personal Instagram story #StayInWorkOut receiving and wellbeing information and support’. relating to care and research and answered relationships and work. They can be so 1,769 views and 33 responses. questions from viewers on things like severe that some women stop taking their This year, Breast Cancer Now fed into NHS mental health, dealing with side effects and prescribed hormonal therapies such as Further activity was due to happen England’s Health and Wellbeing Checklist secondary breast cancer. During the peak of tamoxifen. between June and July 2020 but due to the for Cancer Alliances, which aims to help the pandemic, our broadcasts reached over coronavirus our support for the campaign Alliances deliver this for their patients. 1.5 million people. Hormone Replacement Therapy (HRT) is not was put on hold. Further support for the recommended for women living with or after campaign is due to take place in September To improve follow-up care for patients, breast cancer as it can increase the risk of and October 2020. we also fed into NHS England’s handbook the disease returning and there are currently for implementing Personalised Stratified OUR WORK IN RESEARCH no consistent routes of helping these Scottish Physical Activity and Long Term Follow-Up Pathways. This handbook is women to live well. Having demonstrated Conditions Coalition aimed at supporting local health and that group CBT can be effectively delivered Following on from our involvement and work care systems to provide comprehensive, New project Understanding how weight in the context of the NHS by breast care on the Richmond Group of Charities, Breast personalised follow-up care to their loss could improve breast cancer survival nurses, Professor Fenlon would like to Cancer Now were invited to join the newly patients, including information of signs Dr Rebecca Beeken from the University of see this intervention available to women established Scottish Physical Activity and and symptoms of a recurrence, rapid Leeds wants to see if a diet programme throughout the NHS. Long Term Conditions Coalition in November access back to their cancer team, regular that has previously been successful in 2019. surveillance scans or tests, and support other healthcare settings could benefit planning. overweight women with breast cancer. The coalition is composed of leading OUR WORK IN PUBLIC national health charities who support, Women with excess weight who have been represent and advocate for people with a diagnosed with breast cancer also have a HEALTH AND WELLBEING range of long-term conditions in Scotland higher chance of their cancer returning or along with input and support from a being diagnosed with breast cancer again. We Are Undefeatable range of national agencies and academic They are also more likely to die from breast We Are Undefeatable is a movement to institutions with an interest in health and cancer or other causes. However, since support and encourage people with a range physical activity. weight loss programmes are not currently of long-term health conditions to find ways prescribed as treatment, this leaves it up to be active that work for them, not against The aim of the group is to work together to the individual to lose weight themselves them. to positively influence national and local which can be very difficult. investment in physical activity opportunities

The campaign was developed in for people with long-term conditions, Dr Beeken will see if this programme collaboration with the 15 leading health advocating across policy areas, planning, can effectively support women with and social care charities that make up the provision and delivery of services. The breast cancer to lose weight, bringing Richmond Group of Charities. Breast Cancer group has already met three times since it better quality of life and improved health outcomes.

32 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 33 Strategic report Strategic report

IMAGE

34 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 35 Strategic report Strategic report

To achieve our startegic objectives, we have been OUR DIGITAL WORK OUR PRESS, PR AND CELEBRITY WORK RAISING OUR PROFILE AS THE TRUSTED As part of the launch of our new brand, we brought together online health information Breast Cancer Now is the media’s go- and publications, research project ORGANISATION FOR EVERYONE AFFECTED to source for journalists wanting expert descriptions, fundraising events registration, comment and opinion on breast cancer- volunteer opportunities, and much more – BY BREAST CANCER SO THEY GET THE related stories. across thousands of web pages from our You will read about media coverage two previous charities’ websites – into one we have secured around the charity’s SUPPORT THEY NEED AND ARE INSPIRED TO redesigned website at breastcancernow.org. policy, influencing and campaigning Throughout 2019–20, the website received work, fundraising activity, and research around five million visits. GIVE SUPPORT TO MAKE POSITIVE CHANGE throughout this report. Long-term goals As well as launching the new website, we We have provided expert opinion to every also rebranded our online community Forum national broadcast news outlet – including at forum.breastcancernow.org and Becca, Preventing and detecting breast cancer better Saving lives from breast cancer BBC Radio 4 Today, ITV News at Ten, Channel our post-treatment breast cancer support 4 News, Channel 5 News, Sky News, BBC app. Living well with breast cancer News Channel, BBC Radio Scotland, BBC Radio Wales, Talk Radio and Radio 5 Live – Since then, and thanks to the generosity discussing topics including HRT and breast of the players of the People’s Postcode cancer, secondary breast cancer, long-term Lottery, we have continued to make effects of breast cancer, breast screening improvements to our online donation and and breast awareness. ticketing platform so people can safely than 806,000 people. And our radio adverts and securely donate and take part in our OUR NEW BRAND In Scotland, we have also responded to were heard by over 26 million people. We fundraising events. also partnered with LBC Radio to create a many different breast cancer issues such as the high-profile review of the Scottish On 1 October 2019, the charity launched special week of daily features discussing We have also revamped our In Memory Breast Screening Programme, variations its new brand following the merger of a different aspect of breast cancer with website for people to remember loved ones, in treatment across NHS Tayside, cancer Breast Cancer Care and Breast Cancer Now interviews each day. These were heard by raising money to offer support for today and incidence figures and decisions made on the earlier in the year. We set out to create a over eight million people. hope for the future to people affected by availability of new breast cancer treatments bold brand, building on the heritage of our breast cancer. on Scotland’s NHS – all generating over previous brands, to combine the power of ‘ONE OF THE BEST SPECIAL REPORT WEEKS WE’VE 60 pieces of coverage across a variety of life-changing care and world-class research. EVER RUN ON LBC – THE CONTENT WAS REALLY We brought together social media audiences Scottish media outlets. To mark the start of Breast Cancer INTERESTING & ENGAGING, THE INTERVIEWEES from our two previous organisations,

Awareness Month, we launched our first WERE ALL FANTASTIC AND PROFESSIONAL, AND IT HAS combining them into Breast Cancer Now We have also leveraged wide-ranging brand campaign as a new charity. Named LANDED REALLY WELL WITH OUR LISTENERS.’ pages on Facebook, Instagram, Twitter and PR opportunities to ensure that women ‘What we’ll see’, the campaign highlighted LBC LinkedIn for a total following of around one affected by breast cancer know that they how breast cancer still creates fear, million people. are not alone and are aware of the support contrasted with the hope that Breast By the end of the campaign we had seen that we can offer them. This has included Cancer Now brings through the combined an increase in all of our brand metrics, By maintaining a warm and engaged more than 15 magazine features, three power of research and care. particularly our brand awareness which audience on our Facebook page, between national newspaper features about returning reached its highest yearly score at 51.1% August 2019 and July 2020, we were to work, younger women diagnosed with With a mix of advertising our campaign was (20% higher than September 2019 and 53% delighted to receive nearly £1.4 million from breast cancer and how to breast check. well seen and well received by the public. higher than November 2019 – well exceeding people who created birthday and other Our breast care nurses have also featured Our outdoor advertising – including 50 bus our target of 45%. fundraisers with their friends, family and in five consumer Q&A pieces of coverage, panel adverts and 500 London Underground followers. including in high-circulation titles such as panel adverts – were estimated to reach 3.1 The People’s Friend, Woman’s Own and million people. Our digital advertising across Fabulous. Facebook, Instagram, Twitter, YouTube, Bing and Spotify performed well reaching more

36 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 37 Strategic report

Since August 2019, we have also led with research news stories on topics from molecular understanding of cancer to repurposing existing drugs to help treat breast cancer, gaining national and regional coverage. We have also provided our expert opinion on 15 other research stories in this time.

Through the merger of Breast Cancer Now and Breast Cancer Care, we have strengthened the support we receive from high-profile names. Our Royal Patron is HRH Prince of Wales and we are now fortunate to work with six Vice-Patrons and 18 celebrity Ambassadors.

OUR VOLUNTEERS

People giving up their valuable time to support us is vital in helping to raise our profile and our income. In the past year, over 5,500 volunteers have dedicated their time across 60 different opportunities to support the charity. This includes 526 managed volunteers who support us on an ongoing basis, as well as fundraising and event volunteers, committees, campaigners and Breast Cancer Voices, who all give their time and skills to make positive change. Our support services, office and campaigning volunteers have dedicated nearly 4,500 hours of support to our cause in this financial year.

Our network of Breast Cancer Voices use their experience to help shape our work. They have the chance to get involved with a wide range of our work from giving views on our publications and materials, taking part in photoshoots and telling their stories in our communications to helping us campaign for change and raise awareness of our life- changing care and world-class research. In the past year, the network has grown by 8% to 2,700 members.

38 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 39 Strategic report Strategic report

To achieve our startegic objectives, we have been findings of our survey on breast cancer, for us, raising a wonderful £3.3 million. Our sex and intimacy which was covered in community supporters raised £2.2 million The Sun, metro.co.uk, You magazine and through everything from cake sales, quiz INSPIRING MORE PEOPLE TO SUPPORT huffingtonpost.co.uk. we also secured nights and gala balls to a huge range of features of women affected by breast other activities. US FINANCIALLY TO ALLOW US GROW AND cancer talking about these issues in high- profile consumer publications such as Red During Breast Cancer Awareness Month and Cosmopolitan magazines. 2019, The Show continued to be a highlight DEVELOP AS A SUSTAINABLE ORGANISATION in the events calendar. Through our shows The partnership has raised almost £100,000 in London and Glasgow, more than 50 TO MEET FUTURE DEMANDS in its first year through the sales of courageous models stepped out onto the selected products, customer and employee catwalk following a breast cancer diagnosis fundraising. in front of a collective audience of over 2,500 people, raising over £400,000. Long-term goals In Summer 2020, we worked with ghd to We also returned to St Paul’s Church for our launch their Take Control Now campaign, Carols by Candlelight concert where our featuring 11 women diagnosed with breast guests enjoyed mulled wine and roasted Preventing and detecting breast cancer better Saving lives from breast cancer cancer under the age of 35 who shared chestnuts while raising vital funds for their experiences to remind people to check Breast Cancer Now. Living well with breast cancer their breasts regularly and what to look for. As part of the campaign, ghd created a We raised over £200,000 through our fantastic hairdryer and hair straighteners embossed Women V Cancer partnership, which saw with the words Take Control Now to serve as hundreds of women taking to their bikes and a reminder, and we secured press coverage cycling challenging routes across the UK and in The Express, Fabulous (Sun), The Mirror, as far afield as Kenya and Thailand. OUR FUNDRAISING welcomed CoppaFeel! to our partnership The Metro, Woman & Home and 20 regional to reach more people in the UK with breast titles. Our huge thanks go to the many volunteers awareness messaging. who continue to support us with our Corporate partnerships Other highlights throughout the year fundraising collections and activities. Many Our flagship Asda Tickled Pink partnership Marks and Spencer has continued to include: also organised their own events, which is now award-winning, securing the Most generously support Breast Cancer Now raised nearly £250,000, including: Outstanding Partnership in the Fashion and with a range of fundraising activities. A • W orking alongside easyJet and Prostate Retail sector at the Business Charity Awards highlight included their annual Breast Cancer UK to raise an incredible £218,000 • A member of our East Dunbartonshire and 2020. We are delighted that the partnership Cancer Awareness Month campaign, which through employee fundraising and on- Glasgow Group in Scotland who raised a innovation, disruptive campaigns and raised over £250,000 through the sale of flight donations with our ‘Life Saving staggering £10,000 by holding collections commitment to inform and educate selected sleep and lounge wear and in-store Journeys’ campaign. in local supermarkets and shopping groups with unmet needs with our breast fundraising. To support the campaign, we • L ong-standing partner, Dorothy Perkins, centres. awareness messaging was noted by the generated more than 40 pieces of press continue to raise money through their • O ur Wales Fundraising Committee who judges as sector-leading. coverage, including features in The Sun and hugely successful Pound on the Bill raised over £18,000 through various events The Daily Mail. campaigns alongside raising over £80,000 in the year including a gala ball. Asda had their most successful Breast through the sale of their Breast Cancer Cancer Awareness Month campaign in Marks and Spencer’s post-surgery lingerie Awareness Month clothing range. Our many Clubs and Societies also put on October 2019 with a record number of and swimwear range also continues to • W e also welcomed new partnerships their own events throughout the year, such suppliers contributing through cause- support Breast Cancer Now, with just over with Anglian Water and Careys, both as: related marketing. Coverage of our £370,000 raised. committing to raising money through campaign photo shoot with celebrities, employee fundraising and engagement • R amside Golf Club who raised nearly influencers and people affected by breast We launched a new partnership with Ann activities. £10,000 through their Ladies Captain and a cancer appeared in The Mirror, That’s Life, Summers to help start a conversation about charity golf day. Closer, Bella and The Sun. Over the course issues related to sex and intimacy after a Events and community fundraising • B oobs and Brass, a group of local people in of the year the partnership raised nearly breast cancer diagnosis and raise awareness Our incredible Event fundraisers trekked the Midlands, who came together and held £4 million in total despite the considerable of the support that Breast Cancer Now the desert, ran marathons, climbed musical events throughout the year raising challenges from the coronavirus. We also can offer. This included releasing the mountains, and even walked over hot coals just short of £7,000.

40 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 41 Strategic report Strategic report

Those supporting us in memory of a loved weekly lottery, purchased our scratch cards to enable a step-change to our specialist overseas in the lead up to Christmas. one, in celebration or through a Tribute Fund and merchandise and gave generous support support provision for people facing breast raised an amazing £485,000 during the year. to our appeals and raffles. All of this helped cancer in the North of Scotland. Unfortunately, the coronavirus drastically hit In April 2020, the charity Second Hope us continue our vital services, supporting third party events and after the Bath Half and became part of the Breast Cancer Now people with breast cancer all over of the UK. We were delighted to receive a grant of The Big Half running events at the beginning of family. Second Hope raises funds for In October 2019, the Breast Cancer Research £400,000 from long-standing partners March 2020, unfortunately no further events secondary breast cancer research and due Trust (BCRT) merged with Breast Cancer Walk the Walk, thanks to the support of the could proceed for the remainder of the financial to the success of the charity since 2015, it Now with the aim of funding world-class thousands of walkers who took part in one year. This severely impacted our income, now requires full-time management. Breast research to ensure the best outcomes for of their iconic walking events. This grant particularly a busy Spring season where most of Cancer Now will continue to raise funds people affected by breast cancer, now and will fund the non-salary costs of the cross- our sporting event income is generated. through Second Hope to fund vital research in the future. The BCRT will continue to centre teams at the Breast Cancer Now Toby into secondary breast cancer research. exist as a separate charitable trust but has Robins Research Centre, providing expertise Taking opportunities handed the responsibility for its running and equipment to support all the research Despite this, the organisers of the London Mass participation events to Breast Cancer Now. Existing and future teams based there. Marathon designed The 2.6 Challenge to replace Wear it pink is our flagship mass funds donated to the BCRT will be used to our largest income event (expected to raise participation fundraising event where fund breast cancer research, particularly to We remain grateful to members of the £750,000). We capitalised on this challenge people across the UK wear pink at work, establish Translational Research Fellowships Care Collective for their support of our and encouraged all our supporters to take part home or school, raise money and help us to aimed at improving the outcomes of people community support services, especially and support us at a time where we have never make life-saving research and life-changing diagnosed with breast cancer or those at those members who have now fulfilled the needed them more. They rose to the challenge care happen. 2019 was a fantastic year, risk of the disease. final year of their pledge. and up and down the country, supporters raised raising over £2 million – 20% more than the a fantastic £114,000 across the weekend of the previous year. Legacies Our work has also been supported by planned London Marathon 2020. This year was a more challenging year for generous contributions from donors who Our high-profile press campaign featured legacy income, however we received £1.7 wish to remain anonymous and we would Riding the wave of virtual events, in June in the Daily Mirror, Daily Express and on million from people who were kind enough like to take this opportunity to recognise 2020 we launched Walk 300,000 – Breast the front page of The Guardian. In total, we to leave a gift in their will to support our and thank them all. Cancer Now’s first fundraising product that generated more than 560 pieces of coverage vital work. utilised Facebook’s algorithm and machine reaching 43% of all UK adults. Fundraising during the coronavirus learning to reach an audience who were Philanthropy The coronavirus has had a major impact on our spending an increased amount of time online During July 2019, thousands of people We are hugely grateful to the A Bigger ability to fundraise. Like many other charities, during lockdown. The event was a huge generously held a Breast Cancer Now Bounce Committee for hosting their fourth we had to postpone much of our fundraising success, reaching nearly 1.5 million people Afternoon Tea – gathering in their gardens, A Bigger Bounce event. Thanks to their activity. With a national lockdown and social on Facebook, gaining over 2,500 registrations community centres and public spaces to dedication, the evening was an enormous distancing guidelines in place, national events (94% of participants being new to charity) and, raise money for our vital work. The event success raising over £1 million for vital were cancelled, face-to-face fundraising and ultimately, beat our income target of £37,500 was a huge success, with supporters raising breast cancer research. many of the ways our supporters use to raise with a total income of £357,768. £718,000. money became impossible, and fundraising The Pink Ribbon Ball celebrated its 25th with many of our high-street retail partner was Our supporters in the community continued Individual Giving Anniversary and, thanks to the energy and scaled back or paused. to do all they could to support us despite Tens of thousands of individuals generously hard work of the Committee, raised over challenging times and raised over £1 million supported us through regular direct debits, £240,000 for our support services and With the safety of our supporters and people through their own events – including popular cash, raffle or lottery donations. Their research. affected by breast cancer at the forefront activities like cake sales and coffee mornings. committed support enables us to plan for of our minds, we were forced to make some Walking also continued to prove popular with the future and provide continued, long- We thank the Mary-Jean Mitchell Green difficult decisions. This resulted in the many supporters hosting their own walking term funding which is so important to the Foundation for renewing their generous cancellation of our Pink Ribbon Walks, a series events throughout the summer months. scientists, nurses and services we work support towards Professor Nick Turner’s of events that had been targeted to raise over with. pioneering research. We are incredibly £500,000, as well as planned treks, walks, zip Other highlights included the women’s grateful for their long-standing commitment slides and skydives. The story was the same group, Caravan Girls, who raised a massive Our regular supporters were very generous, to Breast Cancer Now and our Research across our sporting events. The autumn events £18,500 through the sale of calendars. despite difficult times, donating an Centre. season got off to a fantastic start with our And our 46 local groups raised vital funds incredible £11 million – the largest amount largest ever Great North Run team of over 600 and helped promote our breast cancer we have ever received from this group of We are hugely grateful for the William Grant runners raising over £300,000. Quickly followed awareness messages. committed supporters. They supported our Foundation’s focussed investment this year by various other events all over the UK and

42 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 43 The Big Bounce Ball,

44 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 October 201945 Strategic report Strategic report

To achieve our startegic objectives, we have been contribution structure and changing our pension provider.

ESTABLISHING AND EMBEDDING OUR Organisational Design In response to the impact of the coronavirus CULTURE - SHARED ORGANISATIONAL on our income, we undertook a full review of the organisation’s design to ensure the charity met required cost-savings and had VALUES, BEHAVIOURS, TOOLS AND WAYS a structure that was fit for purpose for the 2020-21 financial year. This included OF WORKING - TO ENABLE OUR PEOPLE TO reducing the Senior Leadership Team members from seven to four and a full WORK EFFICIENTLY AND EFFECTIVELY TO consultation process with staff, regrettably resulting in 45 redundancies and the closing DELIVER IMPACT FOR PEOPLE AFFECTED BY of our Edinburgh office. HR Policy Development BREAST CANCER Following the merger, we have reviewed existing HR policies and procedures to put in place one set of policies and procedures Long-term goals for our new charity and established new and better learning and development Preventing and detecting breast cancer better Saving lives from breast cancer opportunities.

Living well with breast cancer Colleague engagement This year we have improved our ability to share important, relevant and timely information with our colleagues across the UK through our intranet – developing the site to become a vital communication Fundraising portfolio analysis This important element of our analysis, channel to update on news, achievements Following our merger in April 2019, we combined with the data of our fundraising and upcoming events. undertook a comprehensive analysis of our performance, has not only highlighted our newly combined fundraising portfolio. strengths but, crucially, has pointed to We also formed our new Staff Forum, made Considering more than just the financial where improvements in systems, practice up of representatives from all areas across element, the project has sought to recognise and resourcing can be made for our the charity, to share and gather feedback the wider value our fundraising activity operations as a united breast cancer charity. from colleagues and have used focus offers to the organisation, enabling us to Over time, as the workings of our merger groups, workshops and regular surveys to identify the most valuable and engaging slot further into place, evidence from this engage colleagues in our work. ways in which our supporters want to get project will influence and drive the rationale involved and raise funds for us. Through behind the development of our fundraising Volunteering this project we also now have a greater strategy aimed at delivering long-term and We have scoped the volunteering understanding of just how many of our sustainable growth in income. opportunities across our newly merged participants have been impacted by breast charity and produced an action plan to cancer in some way. This has deepened our Staff Terms and Conditions Pay and Reward enable us to involve more volunteers, understanding that for many, taking on a This year, in consultation with staff, we have supported by expert staff, to deliver impact challenge, hosting an event, committing to reviewed and developed a new set of terms for people affected by breast cancer. a regular donation or however they choose and conditions and reward structures and to support us, is an important part of how processes that are fit for purpose, sector- Breast Cancer Now can be there throughout leading, accessible to all and championed their breast cancer experience. at the highest level of the organisation. This has included reviewing our pension

46 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 47 Financial review Financial review

The minimum reserves level has been Retention Scheme ensured that we ended FINANCIAL REVIEW calculated taking into account the different the year with a relatively small deficit risk factors that the organisation faces. and unrestricted free reserves of over £12 During the year, the Trustees considered million and cash and cash equivalents of that a sufficient level of reserves for the £22 million. Going forward we continue organisation would be a minimum of three to respond to the pandemic through a months operating costs. The current free reduction in the level of operations for This report covers the period from 1 August increase is lower than expected due to the reserves position of 4.5 months, based on 2020-21 and obtaining specific grant support 2019 to 31 July 2020. impact of the coronavirus which resulted in budgeted expenditure for 2020-21, is in line from the National Lottery Covid-19 support the suspension of community (face-to-face) with this policy. Total funds at the year-end fund to help mitigate the financial impact of Income support services and a reduction in research were £16.1 million. the coronavirus during 2020-21. During the year, total income, excluding activity. furlough income and other income, rose Financial Statements The Board has reviewed the Charity and to £38.4 million from £32.5 million – a Reserves The Charity’s consolidated financial Group’s activities and financial position 18.2% increase. However, the year reflects The net movement in funds was a deficit statements are set out on pages 61 to together with factors likely to affect the 12 months of income from the combined of £255,000. During the year, restructuring 82, including the results of the Charity’s future operations, including the impact of charity (having merged on 1 April 2019) and costs of £653,000 were incurred as part of subsidiaries. The financial results of the economic uncertainty on voluntary income. income being significantly impacted by the the Charity’s response to the coronavirus. Charity’s regional groups are included within A review of a range of scenarios assessing coronavirus, with fundraising income being A budget for 2020-21 has been agreed, the consolidated results, as they operate the impact of the coronavirus on income over 16% lower than planned. reflecting an assessment of the impact within the same charity registration and are projections have confirmed that appropriate on the Charity caused by the coronavirus, governed by the Charity’s regional group actions can be implemented by the Trustees The main sources of income continued to which will continue to ensure that the constitution. to maintain financial reserves within the be individual giving (£15.8 million), corporate Charity is within the reserves policy set out policy range and it is therefore reasonable partnerships (£6.3 million) and events and below. Subsidiary Trading Companies to expect the Charity and Group to have community fundraising (£5.5 million). You The Charity had nine subsidiaries that adequate resources to continue in operation can find more detail about our financial The charity holds reserves to provide are detailed in note 26 of the financial for the foreseeable future, representing performance in these areas, along with funding for long-term financial statements along with their results for the a period of at least 12 months from income generated from mass participation commitments and a contingency against year. The companies are all wholly-owned authorisation of the financial statements. events, and legacy, major gifts and trust unforeseen operational cost pressures or subsidiaries. These subsidiaries carry out fundraising on pages 40 to 43. reduction in income. Each year the Trustees activities such as sub-licensing the Charity’s Given this satisfactory closing position, a review reserves levels in light of the year logo and the Fashion Targets Breast Cancer prudent balanced budget for 2020-21, and Income from charitable activities increased ahead to ensure there are adequate funds to logo to commercial partners and delivering present projections the Trustees consider due to royalties generated from the support the organisation. Reserves are held certain charitable partnerships. BCN it appropriate for the financial statements intellectual property from Breast Cancer in two types: Research Ltd delivers the Breast Cancer to be prepared on a going concern basis Now-funded research activities. Now Catalyst Programme. On 30 April 2020 as outlined in the Statement of Trustees’ • R estricted funds arise as a result of the Second Hope, a registered charity, became a Responsibilities. Fundraising expenditure donor making a specific stipulation as to subsidiary of the Charity (£163,000). Expenditure declined from £18.3 million how the funds may be used. This is often The trading subsidiaries transfer any Grants to £17 million (7.6%), which reflected the relating to a specific activity or grant profits to the Charity under the Gift Aid The Charity funds research of the fact that many of Challenge Events that that may fall over a number of years and scheme and their financial statements are highest quality. We support the scientific usually take place between April and July therefore the balance carried forward consolidated into those of the charity. community across the UK and Europe were cancelled or postponed due to the at the year-end is committed for those through multiple funding mechanisms, coronavirus restrictions. activities. Restricted funds stood at £2.2 Going concern through our Tissue Bank and by supporting million at the year-end. The financial impact of the coronavirus on conferences and training courses. Some of Charitable expenditure • U nrestricted funds arise when no the Charity and Group has been significant. our funding supports centres of excellence, Charitable expenditure, which includes all stipulation is made by the donor. The During 2019–20, whilst some income as we have taken a strategic decision to activities relating to research, provision Trustees are responsible for ensuring these streams were significantly lower, income build a critical mass of research in a small of clinical and support services, policy funds are spent in line with the Charity’s from regular donors and our corporate number of locations. These are based in and campaigning, and public health and objectives in a timely fashion. Unrestricted partners continued to deliver an important higher education institutions and close to information, increased from £21.4 million free reserves, excluding those held in contribution. Additionally, the cost savings hospitals and breast units, working under to £22.6 million (5.6%). This increase intangible and tangible assets of £1.6 we achieved in the four months to 31 July one roof in integrated, multidisciplinary in expenditure reflects the combined million. stood at £12.2 million at the year- 2020 and the additional financial support programmes of research. charitable activities for 12 months. The end. through accessing the Government’s Job

48 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 49 Financial review Governance, structure and management

Investments The Charity holds investments in GOVERNANCE, STRUCTURE AND accordance with the Investment Strategy approved by the Trustees. The Finance and Investment Committee reviews this MANAGEMENT Investment Strategy on an annual basis. The Charity’s investment objective is to maximise the return on its investments in a manner consistent with the Charity’s overall strategy and values while meeting two The Board of Trustees of Breast Cancer Now • A dvance the health of individuals by requirements: presents its Annual Report and Accounts for undertaking research into the causes and the year ended 31 July 2020. These comply treatment of cancer on terms that the 1. Investing to cover certain short-term with the Companies Act 2006, Breast results of such research are published spending with adequate liquidity and a Cancer Now’s governing document the • A dvance public education in and shorter-term risk averse profile Memorandum and Articles of Association, understanding of the nature of cancer 2. Investing longer-term reserves and Accounting and Reporting by Charities: and its treatments, particularly (without consistent with their use for longer-term Statement of Recommended Practice prejudice to that generality) among commitments or as contingency assets applicable to charities preparing their sufferers of cancer and the families, accounts in accordance with the Financial friends and carers of such persons The investments are split into two portfolios Reporting Standards applicable in the UK • Pr omote such charitable objects which are managed by different investment and Republic of Ireland (FRS 102) (effective 1 concerned with medical research or the managers; BlackRock and CCLA. In October January 2015). relief of sickness as the Directors shall in 2019, the Goldman Sachs portfolio was their absolute discretion determine. disinvested, please see note 11 of the Status financial statements. The Finance and Breast Cancer Now is a company limited Trustee recruitment, appointment, Investment Committee consider which are by guarantee, governed by Articles of induction and training the most appropriate investment managers Association, registered in England and Trustees are appointed, by the Board, for and as part of this, they consider their Wales (number 9347608) and registered an initial period of three years that can be mandates, targets for performance and their as a charity in England and Wales (number extended for a further three-year term. A ability to provide the appropriate support, 1160558), Scotland (SC045584) and Isle of further one, two or three-year term can diversification and performance required to Man (number 1200). The Trustees listed on be agreed between the individual and the achieve the investment strategy. page 52 are also the Charity’s Directors and chairperson, or three other directors if have overall responsibility for the strategic deemed to be in the Charity’s best interest. direction and effective governance of the Charity. The Trustees met regularly during Trustees contribute their services voluntarily the year. and upon appointment will participate in a formal induction programme, including The legal and administrative details are attendance at Breast Cancer Now events, listed on page 86. visits to our offices and tours of our research units. Objects The Charity’s objects are to: A skills audit of the Board is performed periodically to ensure the appropriate range • A dvance health, including the health of of skills and expertise, including in areas of individuals suffering from cancer, patients scientific knowledge, organisational strategy receiving treatment, those convalescing and management. following treatment by: - promoting activities which will assist with awareness, identification and prevention of cancer; - assisting those individuals who are disabled, infirm or in need of assistance;

50 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 51 Governance, structure and management Governance, structure and management

Board of Trustees Senior Leadership Team (at 31 July 2020) Our People and Culture Committee, workshops to engage staff in our work Members of the Board during the year were: which superseded the Remuneration, which has helped us shape our approach Delyth Morgan (Chief Executive) Appointments and Nominations Committee in learning and development; reward and Ŧ + ~ Jill Thompson Chair David Crosby (Director of Services) from 1 April 2019, monitors Breast Cancer policy development and to make Breast * Now’s people plan, our organisational and Cancer Now a great and safe place to work. Professor Trevor J Powles Vice Chair (in office until 4 June 2020) cultural development and reward strategy. Their feedback was instrumental in how Ŧ ¥ Pascale Alvanitakis-Guely Fiona Hazell (Director of Communications & This includes our pay and benefits policies, we supported staff on furlough (70% of ¥ Influencing)(in office until 4 June 2020) Mark Astaire our pay structure and annual pay review the workforce) and their return to work + Steve Lucas (Director of Fundraising & process, all of which determine how pay including the development of a virtual Barbara Brown Partnerships) (in office until 1 October 2019) levels are decided. We are committed to staff conference that ran over a week and Christopher Copeland ~ equality in our pay and benefits policy and included presentations from Executive Rachael Franklin (Director of Fundraising & Ŧ ¥ aim to ensure that our levels of pay and Directors, Trustees, Associate Directors and Susan Gallone Partnerships) (in office from 16 March 2020) range of benefits reflect the knowledge, our beneficiaries on the life-changing work Ŧ ¥ Sonia Gayle Polly McGivern (Director of Corporate skills, experience and competencies of our being undertaken and our priorities for the Professor Adrian L Harris *~ Services) (in office until 17 April 2020) staff. coming year.

Dr Marion Lewis + * Chay Champness (Director of Corporate Services) (in office from 6 April 2020) We aim to pay salaries at the median level We recognise and appreciate the work our Andrew Moore ~ of the voluntary sector, and we regularly Staff Forum undertakes. The Staff Forum Emma Pennery (Clinical Director) Ann Pickering + use salary survey data to check that our pay actively seeks and shares the voice of our Simon Vincent (Director of Research) remains in line with the market we operate staff with our Senior Management Team, in. The Committee approves the annual our Organisational Management Team and Ŧ member of the finance and investment During the year, the SLT were regarded as pay review process, which is determined our Trustee’s through the People & Culture committee the Charity’s key management personnel per partly by average pay awards across the Committee. During the last year, we have ¥ member of the risk and governance committee FRS102. Total earnings, including pension sector, and partly by the charity’s financial consulted with our staff through the Staff contributions, received by members of the performance and affordability to fund an Forum on our new terms and conditions + member of the people and culture committee SLT during the year were £824,059 (2018-19 annual cost of living increase. and pay structure; our HR policy portfolio * member of the science strategy committee £738,000). and following the impact of coronavirus Executive pay is governed by the same rules a restructuring programme unfortunately ~ member of the strategy committee As part of the restructuring due to the and review processes as for all other staff, resulting in 45 redundancies. Their insight coronavirus, two directors were made and we offer the same level of benefits and constructive feedback on behalf of staff redundant and severance payments which to the executive team as to the rest of was pivotal in helping us undertake these The Trustees have the benefit of a qualifying totalled £124,431 are included in these our staff. Jobs are evaluated and graded programmes in an effective, collaborative third-party indemnity provision as defined costs. In 2019–20, the Chief Executive, the into a framework with pay bands that are and informed manner. by section 234 Companies Act 2006. highest paid member of staff, received transparent and published to all staff. The Charity purchase and maintained remuneration of £122,378 (the assessment Our Trustees freely give their time and do Equality throughout the year Trustees’ and Officers; of the highest paid member of staff in the not receive payment for the work they do, Breast Cancer Now acknowledges that liability insurance in respect of itself and its year excluded any termination benefits paid) other than travel expenses. everyone is unique with individual skills, Trustees. knowledge and life experiences and In response to the impact of the coronavirus Information everyone can make a valuable and positive Chief Executive and management on our income all members of the SLT We provide staff with information on contribution to the aims, values and Day-to-day management of the Charity is agreed to a temporary reduction in their matters of concern to them through various strategic goals of the charity. We recognise delegated to the Chief Executive assisted basic salary between April and July 2020. channels of communication including the the benefits of employing and engaging by the Senior Leadership Team (SLT), other intranet, newsletters, team briefings, and with individuals from all backgrounds and staff and volunteers. The Board approves Staff employee reward informal monthly face-to-face meetings community groups as this helps build a the delegation of financial authority through From August 2019 to July 2020, Breast led by our Chief Executive and Directors workforce and business where creativity the Chief Executive to the staff with specific Cancer Now employed an average of to update staff on important news, and valuing difference in others thrives. limits imposed within and approved scheme 311 staff across the year. Our staff are achievements and upcoming events. We are committed to a policy that ensures of delegation. fundamental to the work we do and we rely all current and potential staff members on them, our supporters, volunteers and Over the past year we have taken time and volunteers are offered the same trustees, and their amazing commitment, to listen to how our staff feel about opportunities regardless of their sex, sexual dedication and support they give to the working for our organisation through orientation, age, disability, gender status (in charity. staff and pulse surveys, focus groups and cases of gender re-assignment), pregnancy

52 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 53 Governance, structure and management Governance, structure and management and maternity status, marital status, • W e aim to inspire people to give or raise Breast Cancer Now is registered with the ADVISORY BOARDS AND race and religion and belief (protected money for Breast Cancer Now Fundraising Regulator, has paid the levy and characteristics) and membership of or • W e thank supporters appropriately and adheres to the Code of Fundraising Practice. COMMITTEES activities as part of a trade union, or social demonstrate the difference their money Breast Cancer Now fully complies with the or economic status. makes requirements of the Fundraising Preference • W e keep supporters’ data secure and do Service. Finance and Investment Committee An Equality, Diversity and Inclusion not sell or share it for marketing purposes The Finance and Investment Committee is (EDI) Group has been formed to steer • W e manage agencies working for us closely Breast Cancer Now’s fundraising activities responsible for advising the Board on short the development, implementation and and demand high standards of them to and compliance with fundraising regulations and long-term financial planning, including monitoring of an organisation wide approach ensure supporters and the wider public do and best practice are closely scrutinised by review of financial plans, budgets and to EDI, which will enable us to better reach not feel pressured to give and are treated our Risk and Governance Committee, which proposals, as well as playing a governance and meet the needs of both internal and with respect at all times in turn reports to our Board of Trustees. role with the review of financial policies, external stakeholders. • W e listen to our supporters and learn from processes and controls and advising on what they tell us, what they respond to Complaint Handling the appointment of external auditors. The The Group is using management information, and how they want to be communicated At Breast Cancer Now, we aim to maintain committee also sets and recommends external expertise and insight from lived with – so we can continually improve high standards in all our work, but we the investment strategy to the Board for experiences, to enable us to work towards • W e have developed a Vulnerable Persons’ recognise that there may be instances approval and oversees the management and our strategic objectives. It will ensure Policy which our Fundraising staff and where we don’t get it right, or meet the performance of investments. The Finance diverse voices are listened to, foster an agencies working on our behalf are expectations of our supporters, despite our and Investment Committee met three times inclusive environment for all colleagues required to adhere to, to ensure we best intentions. If, and when, this occurs we during the year. and ensure we are reaching and supporting fundraise appropriately and vulnerable will always act quickly to manage, resolve diverse beneficiaries through our charitable people are respected and protected. and communicate the issues, and review the Risk and Governance Committee work. measures we have in place to prevent any The Risk and Governance Committee set the Breast Cancer Now continues to have a reoccurrences. risk management process and ensure that Our fundraising ethos cross-organisational focus on ensuring that strategic risks are identified, reported to the All of our donations come from the public we are working in a way which is compliant From July 2019 to August 2020 we received Board and, where necessary, highlighted to and our partners. Whether someone with law and regulations governing charity and responded to 119 complaints, which is a other committees, such as the finance and donates, fundraises or volunteers for us, fundraising, including GDPR, and which 55% decrease on the number of complaints investment committee. we aim to build strong, respectful and meets the expectations of our supporters. compared to last year. The most common empowering relationships with all our This focus ensures we are adapting to any source of complaints was around our The Committee ensures that risk priorities supporters. It is only through the generosity changes in the law or in best practice and face-to-face fundraising activity. Other and relevant actions are highlighted to the of these individuals, companies and continuously consider what is important to complaints across the year covered our Senior Leadership Team for further action organisations that we can continue to fund our supporters with regards to their privacy direct marketing, fundraising from business by their directorates. The Committee our work. and data. and volunteer-led fundraising. Whilst also oversees any material internal the number of complaints we received is controls change programme and ensures We cannot reach our 2050 ambition alone, Breast Cancer Now employs a number of small compared to the overall reach, each recommendations are implemented. The and so we take great pride in striving for carefully selected professional fundraising complaint has been thoroughly investigated Committee recommends the charity’s risk fundraising excellence, maintaining high agencies to solicit donations on our behalf and corrective action and feedback to management appetite and policy to the standards when handling information by door-to-door, private site and telephone improve the work that we do has been taken Board for approval and reviews policies about our supporters, and respecting their and SMS channels. We manage our agencies as appropriate. We continue to review our which may result in significant reputational preferences. As a new charity, we will closely and require them to be compliant policies and procedures to ensure that are risk. The Risk and Governance Committee continue to work hard on this as we bring with the Fundraising Regulator’s Code of robust and serve our supporters how they met once during the year. together our fundraising and fundraisers Fundraising Practice and all regulations need. from both Breast Cancer Care and Breast governing charity fundraising. To ensure People and Culture Committee Cancer Now. the agencies we engage are operating The People and Culture Committee has to the required standards, we carry out delegated responsibility from the board for From April 2019, when we merged to appropriate and regular monitoring which the remuneration and reward framework become one charity, we brought together includes one or more of the following across the organisation and appointment of two fundraising programmes both focusing as appropriate: shadowing individual Trustees, and Senior Leadership including on providing excellent supporter experience fundraisers, mystery shopping and caller the Chief Executive. The Committee also has and raising vital funds for research and care. monitoring. strategic oversight of the charity’s people The following principles guide our combined plan. The People and Culture Committee fundraising strategy and operations: met once during the year.

54 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 55 Governance, structure and management Governance, structure and management

Science Strategy Committee to manage them. The registers are a living Risk Mitigation The Science Strategy Committee is document that continues to change over responsible for making recommendations time in response to internal and external Coronavirus (COVID-19) pandemic to the Board as to which research projects stimuli. Inability to deliver our vision to • Business continuity focus by Trustees, Senior Leadership team, should be funded and plays a key role those affected by breast cancer led and co-ordinated by Chief Operating Of ficer. in ensuring that our research supports Risks are scored in terms of likelihood and due to the coronavirus pandemic. • Agile governance arrangement, enabling quick and effective our strategic aims. The Science Strategy impact. This allows us to quickly identify decision making. Committee met once during the year. the most pressing risks and any changes in • Robust IT infrastructure enabling staff to work remotely. their profile. For each risk the registers set • Agile implementation of digital solutions. Strategy Committee out the possible causes, current controls in The Strategy Committee is a temporary place to manage it and any actions ongoing committee assisting the Board in developing to provide further mitigation. These actions Fundraising income the charity’s strategy and framework to are assigned an owner, and progress is accurately measure the impact of the tracked by the Senior Leadership Team and Significantly reduced income from • Acceleration and expansion of online fundraising products charity. The Committee also reviews the Trustees. fundraising activities as a result including both pivoting existing events to virtual (Tour de Law) strategic changes to the charity’s activities of the coronavirus pandemic. and initiating new Facebook based virtual events (e.g. Walk prior to consideration by the Board or its The Trustees reviewed Breast Cancer This includes the cancellation 400,00, Run 100,000). committees. The Strategy Committee met Now’s key risks and are satisfied that and postponement of fundraising • Accessing opportunities for coronavirus emergency funding events, the challenging economic from major funders. three times during the year. risk management has been undertaken environment, increased • Ensuring close relationships with major partners and funders appropriately and that adequate systems competition from other charities Chairs’ Committee were in place to manage risk. The Senior and any other social, political or to align strategic priorities and focus on opportunity for The Chairs’ Committee enables decisions Leadership Team are responsible for the economic event, (e.g. impact of a fundraising in challenging environment. to be made between Board meetings where day-to-day risk management and ensuring No Deal Brexit). • Strong and powerful external communications about the impact of the coronavirus on Breast Cancer Now and people they are of sufficient urgency that it would that each directorate is aware of, and affected by breast cancer to build the case for giving. be detrimental to wait until the next Board appropriately manages, their risks. • Accessing the Government Job Retention Scheme fund. meeting. Due to the coronavirus, the Chairs’ We have considered the key risks facing • Increased monthly financial monitoring focusing on cash Committee to meet five times during the the charity in the year ahead and have collection, measures to reduce costs and maximising existing year. assessed the impact of the coronavirus income streams. across the range of strategic risks than as a • Ongoing review of performance to allow flex to activity to build Risk specific risk itself. These strategic risks and on strong performance. Risk is inherent within all of our activities mitigations to manage them are: • Focus on development of new and additional sources of income. and therefore must be understood and managed. Accepting a certain level of risk allows us to innovate and strive to achieve Failure to anticipate or respond to • Acceleration of increased delivery of fundraising, supporter more for people affected by breast cancer. significant changes in supporter care and services via online technology. behaviour and preferences arising • Structural changes to team to develop centralised Strategic It is important, however, to balance risk from the coronavirus pandemic Insight function to increase focus on supporter insight and across the organisation to ensure that it and other social and economic performance. remains within our current level of appetite trends. • External horizon scanning to understand and respond to short and tolerance. and longer trends and attitudinal changes. We operate a process of risk identification and management that is embedded into Research activities the governance of the organisation. Central to this are our risk registers, which are regularly reviewed and updated by the Inability to maintain our • Temporary pausing of schemes for new grants. Senior Leadership Team, the Trustees and commitments to our long-term • Close communication with those researchers to whom we research activities or to fund provide long-term support, to discuss ways of mitigating the considered by the Risk and Governance future research, because of lower impact of reductions in budgets. Committee which normally meets twice a levels of income thanks to the year. coronavirus pandemic and other • Provision of supplements to grants funded in previous years to economic factors. support them during coronavirus disruption and ensure that We also regularly adapt the content to research we have already committed to can be completed. ensure we capture our understanding of our biggest risks and what we need to do

56 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 57 Governance, structure and management Statement of Trustees’ Responsibilities

Risk Mitigation Inability of existing research to • Close communication with researchers and senior STATEMENT OF TRUSTEES’ continue due to disruption at administrative staff at key host institutions to monitor their research host institutions or loss ability to support the research we fund. RESPONSIBILITIES of key researchers. • Long-term commitment to key strategic research activities to ensure stability for research staff and support for research training.

Governance and compliance The Trustees (who are also directors of • prepare the financial statements on Breast Cancer Now for the purposes of the going concern basis unless it is Inability to deliver our strategic • Comprehensive governance structure with Board Committees company law) are responsible for preparing inappropriate to presume that the objectives and respond to specifically in place to review governance and compliance. the Trustees’ Annual Report (including charitable company will continue in a number of risks which are • Dedicated Compliance Officer and Governance team. the Strategic Report) and the financial business. heightened during the coronavirus • Regular training for staff. statements in accordance with applicable pandemic: • Serious data security breach • Enhanced performance management programme for staff. law and regulation. The Trustees are responsible for keeping (from a cyber-attack or non- • External peer review of research. adequate accounting records that are compliance with GDPR). • IT policies and procedures including vulnerability scanning and Company law requires the trustees to sufficient to show and explain the charitable • Lack of compliance with penetration testing and anti-virus software. prepare financial statements for each company’s transactions and disclose regulations in relation to our financial year. Under that law the Trustees with reasonable accuracy at any time the fundraising practices. have prepared the financial statements in financial position of the charitable company • Failure to comply with legal or regulatory requirements. accordance with United Kingdom Accounting and the group and enable them to ensure Standards, comprising FRS 102 “The that the financial statements comply with Financial Reporting Standard applicable the Companies Act 2006. They are also Staff and volunteers in the UK and Republic of Ireland”, and responsible for safeguarding the assets of the applicable law (United Kingdom Generally charitable company and the group and hence Failure to address the health • Regular staff updates via virtual platforms including a staff Accepted Accounting Practice). for taking reasonable steps for the prevention and wellbeing of employees and conference. and detection of fraud and other irregularities. volunteers and support their • Additional guidance and support for staff around remote Under company law the Trustees must not ability to perform their roles working. approve the financial statements unless The Trustees are responsible for the during the coronavirus pandemic and beyond. • Ongoing engagement with volunteers. they are satisfied that they give a true and maintenance and integrity of the charitable • Temporar y closure of of fices in accordance with Government fair view of the state of the affairs of the company’s website. Legislation in the United guidance. charitable company and the group and of Kingdom governing the preparation and • Risk assessment for the re-opening of some offices for a pool of the incoming resources and application dissemination of financial statements may staff to ensure continued wellbeing. of resources, including the income and differ from legislation in other jurisdictions. • Engagement of staff through surveys to identify concerns of expenditure, of the charitable company for staf f about return to the of fice and working remotely. that period. In preparing these financial In the case of each Trustee in office at the date • Expansion and re-focus of diversity initiatives across the statements, the trustees are required to: the Trustees’ Report is approved: Charity. (a) so far as the Trustee is aware, there is • Development of online learning and development platform. • s elect suitable accounting policies and then no relevant audit information of which the apply them consistently; company’s auditors are unaware; and • obs erve the methods and principles in Financial sustainability the Statement of Recommended Practice: (b) they have taken all the steps that they Accounting and Reporting by Charities ought to have taken as a Trustee in order to Failure to effectively manage our • Prudent 2020-21 budget and reserves policy. (2015); make themselves aware of any relevant audit financial resources to ensure we • Enhanced cashflow forecasting to 31 December 2021. • ma ke judgments and estimates that are information and to establish that the company’s can continue to support those • Agile fundraising strategy with quarterly reviews around affected by breast cancer during reasonable and prudent; auditors are aware of that information. performance to date and future pipeline. the coronavirus pandemic and • s tate whether applicable UK Accounting beyond. • Introduction of monthly updates to year-end forecast. Standards, comprising FRS 102, have been followed, subject to any material departures disclosed and explained in the Sue Gallone, Trustee financial statements; and

58 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 59 Independent Auditors’ Report Independent Auditors’ Report

Strategic Report and Trustees’ Annual INDEPENDENT AUDITORS’ REPORT However, because not all future events or Report conditions can be predicted, this statement In our opinion, based on the work is not a guarantee as to the Group’s and undertaken in the course of the audit the TO THE MEMBERS AND TRUSTEES OF parent charitable company’s ability to information given in the Trustees’ Annual continue as a going concern. Report, including the Strategic Report, for BREAST CANCER NOW the financial year for which the financial Reporting on other information statements are prepared is consistent with The other information comprises all of the the financial statements; and the Strategic information in the Annual Report other than Report and the Trustees’ Annual Report the financial statements and our auditors’ have been prepared in accordance with REPORT ON THE AUDIT OF THE Basis for opinion report thereon. The Trustees are responsible applicable legal requirements. We conducted our audit in accordance for the other information. Our opinion on FINANCIAL STATEMENTS with International Standards on Auditing the financial statements does not cover the In addition, in light of the knowledge and (UK) (“ISAs (UK)”) and applicable law. Our other information and, accordingly, we do understanding of the Group and parent Opinion responsibilities under ISAs (UK) are further not express an audit opinion or, except to charitable company and its environment In our opinion, Breast Cancer Now’s Group’s described in the Auditors’ responsibilities the extent otherwise explicitly stated in this obtained in the course of the audit, we are financial statements and parent charitable for the audit of the financial statements report, any form of assurance thereon. required to report if we have identified any company financial statements (the “financial section of our report. We believe that material misstatements in the Strategic statements”): the audit evidence we have obtained is In connection with our audit of the financial Report and the Trustees’ Annual Report. We sufficient and appropriate to provide a basis statements, our responsibility is to read have nothing to report in this respect. • give a true and fair view of the state of for our opinion. the other information and, in doing so, the Group’s and of the parent charitable consider whether the other information is Responsibilities for the financial company’s affairs as at 31 July 2020 and Independence materially inconsistent with the financial statements and the audit of the Group’s incoming resources and We remained independent of the charitable statements or our knowledge obtained application of resources, including its company in accordance with the ethical in the audit, or otherwise appears to be Responsibilities of the Trustees for the income and expenditure, and cash flows, requirements that are relevant to our audit materially misstated. If we identify an financial statements for the year then ended; of the financial statements in the UK, apparent material inconsistency or material As explained more fully in the Statement of • have been properly prepared in which includes the FRC’s Ethical Standard misstatement, we are required to perform Trustees’ Responsibilities set out on page accordance with United Kingdom and we have fulfilled our other ethical procedures to conclude whether there is 59, the Trustees are responsible for the Generally Accepted Accounting Practice responsibilities in accordance with these a material misstatement of the financial preparation of the financial statements in (United Kingdom Accounting Standards, requirements. statements or a material misstatement of accordance with the applicable framework comprising FRS 102 “The Financial the other information. If, based on the work and for being satisfied that they give a Reporting Standard applicable in the UK Conclusions relating to going concern we have performed, we conclude that there true and fair view. The Trustees are also and Republic of Ireland”, and applicable We have nothing to report in respect of the is a material misstatement of this other responsible for such internal control as law); and following matters in relation to which ISAs information, we are required to report that they determine is necessary to enable the • have been prepared in accordance with (UK) require us to report to you when: fact. We have nothing to report based on preparation of financial statements that are the requirements of the Companies these responsibilities. free from material misstatement, whether Act 2006, the Charities and Trustee • t he Trustees’ use of the going concern due to fraud or error. Investment (Scotland) Act 2005 and basis of accounting in the preparation With respect to the Strategic Report and regulations 6 and 8 of the Charities of the financial statements is not Trustees’ Annual Report, we also considered In preparing the financial statements, the Accounts (Scotland) Regulations 2006 appropriate; or whether the disclosures required by the UK Trustees are responsible for assessing the (as amended). • t he Trustees have not disclosed in the Companies Act 2006 have been included. Group’s and parent charitable company’s financial statements any identified ability to continue as a going concern, We have audited the financial statements, material uncertainties that may cast Based on the responsibilities described disclosing as applicable, matters related to included within the Annual Report and significant doubt about the Group’s and above and our work undertaken in the going concern and using the going concern Accounts (the “Annual Report”), which parent charitable company’s ability to course of the audit, ISAs (UK) require us also basis of accounting unless the Trustees comprise: the Group and parent charitable continue to adopt the going concern basis to report certain opinions and matters as either intend to liquidate the Group and company balance sheets as at 31 July 2020; of accounting for a period of at least described below. parent charitable company or to cease the consolidated statement of financial twelve months from the date when the operations, or have no realistic alternative activities, incorporating an income and financial statements are authorised for but to do so. expenditure account, consolidated cash issue. flow statement for the year then ended; and the notes to the financial statements.

60 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 61 Independent Auditors’ Report Financial statements and notes

Auditors’ responsibilities for the audit of the OTHER REQUIRED REPORTING financial statements CONSOLIDATED STATEMENT OF We have been appointed as auditors Matters on which we are required to report under section 44(1) of the Charities and by exception FINANCIAL ACTIVITIES Trustee Investment (Scotland) Act 2005 Under the Companies Act 2006 and the (incorporating an income and expenditure account) and under the Companies Act 2006 and Charities Accounts (Scotland) Regulations For the year ended 31 July 2020 report in accordance with the Acts and 2006 (as amended) we are required to relevant regulations made or having effect report to you if, in our opinion: thereunder. • we have not received all the information Unrestricted Restricted Total Unrestricted Restricted Total Our objectives are to obtain reasonable and explanations we require for our audit; assurance about whether the financial Funds Funds 2020 Funds Funds 2019 or Note £000 £000 £000 £000 £000 £000 statements as a whole are free from • adequate and proper accounting records material misstatement, whether due to have not been kept by the parent fraud or error, and to issue an auditors’ charitable company or returns adequate Income from: report that includes our opinion. Reasonable for our audit have not been received from assurance is a high level of assurance, but Donations and legacies 2 19,186 3,816 23,002 18,388 3,069 21,457 branches not visited by us; or Charitable activities 5,579 - 5,579 3,842 - 3,842 is not a guarantee that an audit conducted • certain disclosures of Trustees’ Other trading activities 3 9,013 481 9,494 6,102 853 6,955 in accordance with ISAs (UK) will always remuneration specified by law are not Investments 276 - 276 252 - 252 detect a material misstatement when it made; or exists. Misstatements can arise from fraud • the parent charitable company financial Other income 24 - - - 9,269 6 9,275 or error and are considered material if, statements are not in agreement with the Furlough income 25 1,686 - 1,686 - - - individually or in the aggregate, they could accounting records and returns. Total income 35,740 4,297 40,037 37,853 3,928 41,781 reasonably be expected to influence the economic decisions of users taken on the We have no exceptions to report arising Expenditure on raising funds 4 17,032 - 17,032 18,292 - 18,292 basis of these financial statements. from this responsibility. Expenditure on charitable activities 5 19,344 3,275 22,619 15,585 5,805 21,390 Total expenditure 36,376 3,275 39,651 33,877 5,805 39,682 A further description of our responsibilities for the audit of the financial statements Net realised investment gain/(loss) 8 - 8 (36) - (36) is located on the Financial Reporting Council’s website at: www.frc.org.uk/ Net unrealised investment (loss)/gain (649) - (649) 842 - 842 auditorsresponsibilities. This description Total net investment (loss)/gain (641) - (641) 806 - 806 forms part of our auditors’ report. Frances Cucinotta (Senior Statutory Auditor) Net (expenditure)/income (1,277) 1,022 (255) 4,782 (1,877) 2,905 Use of this report for and on behalf of PricewaterhouseCoopers LLP Chartered Accountants and Statutory Auditors This report, including the opinions, Other recognised gains/(losses): London has been prepared for and only for the Other recognised gains 24 - - - 2,672 - 2,672 charity’s members and Trustees as a body Net movement in funds (1,277) 1,022 (255) 7454 (1,877) 5,577 in accordance with section 44(1)(c) of the 29 March 2021 Charities and Trustee Investment (Scotland) Funds brought forward 19 15,094 1,261 16,355 7,640 3,138 10,778 Act 2005 and the Companies Act 2006 Funds carried forward 19 13,817 2,283 16,100 15,094 1,261 16,355 and regulations made under those Acts (regulation 10 of the Charities Accounts (Scotland) Regulations 2006 (as amended) The Consolidated Statement of Financial Activities is for the Group as a whole. Total income for the year for and Chapter 3 of Part 16 of the Companies the parent charity was £40,473,000 (2019: £41,991,000). Act 2006) and for no other purpose. We All amounts relate to continuing operations. All gains and losses recognised in the year are included in the do not, in giving these opinions, accept or Consolidated Statement of Financial Activities. There are no material differences between the net income for assume responsibility for any other purpose the financial year and the historical cost equivalents. or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

62 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 63 Financial statements and notes Financial statements and notes

BALANCE SHEETS CONSOLIDATED CASH FLOW STATEMENT As at 31 July 2020 For the year ended 31 July 2020

Group Group Charity Charity Group Group 2020 2019 2020 2019 2020 2019 Note £000 £000 £000 £000 Note £000 £000 £000 £000

Fixed assets Cash flows from from operating activities: Net cash (used)/generated in operating activities a 4,226 (6,504) Intangible assets 9 643 373 643 373 Tangible assets 10 1,000 1,418 1,000 1,418 Cash flows from investing activities Investments 11 8,522 15,279 8,522 15,279 Dividends, interest and rents from investments 146 78 Total Fixed assets 10,165 17,070 10,165 17,070 Cash acquired from Breast Cancer Care 24 - 5,546 Purchase of tangible fixed assets 10 (48) (374) Current assets Purchase of intangible fixed assets 9 (467) (196) Current investments 12 - 4 - 4 Proceeds from sale of investments 11 6,198 5,567 Stock 14 25 - - Net cash generated investing activities 5,829 10,621 Debtors 14 7,312 12,547 9,791 11,751 Cash at bank and in hand 22,086 12,027 11,666 3,667 Change in cash in the reporting period 10,055 4,117 Total Current assets 29,412 24,603 21,457 15,422 Cash at the beginning of the reporting period 12,031 7,914 Cash at the end of the reporting period b 22,086 12,031

Creditors: amounts falling due within one year 15 (15,921) (17,801) (10,891) (12,966) (a) reconciliation of net incoming resources to net cash flow Group Group from operating activities 2020 2019 Net current assets 13,491 6,802 10,566 2,456 £000 £000

Net (deficit)/income for the reporting period Total assets less current liabilities 23,656 23,872 20,731 19,526 (as per the Statement of Financial Activities) (255) 5,577 Depreciation and amortisation 9,10 615 450 Creditors: amounts falling due after more than one year 16 (7,039) (6,864) (4,127) (3,095) Gain on acquisition of Breast Cancer Care 24 - (11,947) Provisions for liabilities 18 (517) (653) (517) (653) Loss on disposal of fixed assets 48 - Net assets 16,100 16,355 16,087 15,778 (increase)/decrease in provisions (136) 96 (Realised gains)/losses on investments 11 (8) 36 Unrestricted Funds 19 13,817 15,094 13,804 14,517 Unrealised loss/(gain) on investments 11 649 (842) Restricted Funds 19 2,283 1,261 2,283 1,261 Dividends, interest and rents from investments (276) (252) Investment fees deducted from portfolio 11 48 35 Decrease in stock 11 31 Total Funds 16,100 16,355 16,087 15,778 Decrease/(increase) in debtors 5,235 (2,125) (Decrease)/Increase in creditors (1,705) 2,437 The notes on pages 66 to 85 form part of these financial statements. The Charity’s net movement in funds for Net cash generated from/(used in) operating activities 4,226 (6,504) the year was an increase of £0.3m (2019:increase of £5.0m) (b) Analysis of cash and cash equivalents Group Group The financial statements of Breast Cancer Now (Company No: 9347608) were approved by the Board of 2020 2019 Trustees and authorised for issue on 29 March 2021 and were signed on its behalf. £000 £000

Cash in hand 20,059 10,515 Notice deposits (less than 3 months) 2,027 1,512 Long-term deposits - 4 Susan Gallone Total cash and cash equivalents 22,086 12,031 Trustee

64 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 65 Financial statements and notes Financial statements and notes

to expect the Charity and Group’s to have gains in the profit and loss account. In NOTES TO THE FINANCIAL STATEMENTS adequate resources to continue in operation circumstances where the fair value of the for the foreseeable future, representing assets received exceeds the fair value of the For the year ended 31 July 2020 a period of at least 12 months from liabilities assumed, only the element of the authorisation of the financial statements. gain which relates to the realised profits is recognised as ‘Other income’ in the SOFA. Given this satisfactory closing position, a The element of the gain which relates to prudent balanced budget for 2020-21, and unrealised profits is recognised as ‘Other present projections the Trustees consider recognised gains’ in the SOFA. 1. ACCOUNTING POLICIES Act 2006, the Charities Act 2011, the it appropriate for the financial statements Charities and Trustee Investment (Scotland) to be prepared on a going concern basis Funds Charity information Act 2005 and the Charities Accounts as outlined in the Statement of Trustees’ The following funds are held by the Charity: Breast Cancer Now (‘the Charity’) is a Public (Scotland) Regulations 2006. Responsibilities. Benefit Entity which was incorporated on 9 *Unrestricted funds are donations and December 2014, and is registered in England The functional currency of the Group and Consolidation other income receivable or generated from and Wales (company number 09347608) Charity is considered to be GBP because The financial statements consolidate the objects of the Charity without further and in the Isle of Man (company number that is the currency of the primary economic the Charity and its trading subsidiaries specified purpose and are available as 6021F). It was registered as a charity on 18 environment in which the Charity operates. (“Group”). The income and expenditure general funds. February 2015 with the Charity Commission from the date of acquisition has been in England and Wales (charity number Going concern incorporated in these financial statements. *Restricted funds arise when conditions 1160558), in Scotland (charity number The financial impact of the coronavirus on A subsidiary is an entity controlled by the are imposed by the donor, or by the specific SC045584) and the Isle of Man (charity the Charity and Group has been significant. Group. Control is the power to govern the terms of the appeal, and can only be spent number 1200). The Charity was established During 2019–20, whilst some income financial and operating policies of an entity on the activities specified. following the merger of Breakthrough Breast streams were significantly lower, income so as to obtain benefits from its activities. Cancer and Breast Cancer Campaign on 1 from regular donors and our corporate The Charity relies heavily on donations and April 2015. On 29 April 2019, the Charity, partners continued to deliver an important Exemptions legacies, which fluctuate year on year. In following approval by the Trustees, acquired contribution. Additionally, the cost savings The Charity has taken advantage of the order to continue day-to-day operations, Breast Cancer Care. we achieved in the four months to 31 July exemption in section 408 of the Companies the Trustees have identified that a minimum 2020 and the additional financial support Act from disclosing its individual Statement level of unrestricted funds should be On 31 October 2019, the Charity completed through accessing the Government’s Job of Financial Activities. maintained. This minimum level of funds is a Deed of Gift with Breast Cancer Research Retention Scheme ensured that we ended kept under annual review by the Trustees in Trust. The gift has been recognised in the year with a relatively small deficit Business combinations line with the reserves policy as described in the Statement of Financial Activities and unrestricted free reserves of over £12 Business combinations are accounted for by the Trustees report (page 48). in the financial year. On 30 April 2020, million and cash and cash equivalents of applying the purchase method. The cost of a the Charity became the sole Corporate £22 million. Going forward we continue business combination is the fair value of the Income Trustee of Second Hope (Registered to respond to the pandemic through a consideration given, liabilities incurred or Income is accounted for and included in Charity No:1163205) a charity committed reduction in the level of operations for assumed and of equity instruments issued the SOFA when the Group is entitled to to supporting research in secondary breast 2020-21 and obtaining specific grant support plus the costs directly attributable to the the income, receipt can be quantified and cancer. Second Hope has been consolidated from the National Lottery Covid-19 support business combination. For combinations at receipt is probable. Income is deferred when in the financial statements as a subsidiary. fund to help mitigate the financial impact of nil or nominal consideration which are in it relates to future accounting periods. the coronavirus during 2020-21. substance a gift, any excess of the fair value Basis of preparation of the assets received over the fair value of Donations These financial statements are prepared The Board has reviewed the Charity and the liabilities assumed is recognised as a Donations are recognised upon receipt along under the historical cost convention, as Group’s activities and financial position gain in the Statement of Financial Activities with any related gift aid. Donations which modified by the inclusion of investments at together with factors likely to affect the (“SOFA”). On acquisition, the fair values have been collected by a third party but not fair value and in accordance with Financial future operations, including the impact of are attributed to the identifiable assets, yet passed to the Charity are accrued based Reporting Standard 102 (‘FRS 102’) ‘The economic uncertainty on voluntary income. liabilities and contingent assets. on the date of collection. Financial Reporting Standard applicable in A review of a range of scenarios assessing the United Kingdom and Republic of Ireland’ the impact of the coronavirus on income Since the Charity is a charitable company, Legacies and with the Statement of Recommended projections have confirmed that appropriate it is subject to the restriction in the Legacies are recognised when capable of Practice ‘Accounting and Reporting by actions can be implemented by the Trustees Companies Act Accounts Regulations that financial measurement, receipt is probable Charities’ FRS 102 as revised in 2019 (‘the to maintain financial reserves within the prohibits the recognition of unrealised and where there are no conditions that SORP 2019’), together with the Companies policy range and it is therefore reasonable

66 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 67 Financial statements and notes Financial statements and notes

still need to be fulfilled. Pecuniary legacies Regional Groups clinical support, health information and Value Added Tax is only partially recoverable are recognised once notification has been The income of regional fundraising groups policy and campaign costs and research by the Charity and therefore the non- received and probate has been granted. includes all transactions cleared on the grant expenditure. recoverable element is included with the Residuary legacies are recognised once regional group bank statements up to the expenditure on which the VAT was charged notification has been received, probate year-end. Research grants in furtherance of the in the SOFA. has been granted and they can be reliably Charity’s objectives are the total amounts measured, usually on receipt of estate Fundraising events granted to external bodies for charitable The Charity’s subsidiaries do not generally accounts. Revenue is recognised at the date of event. work. The grants made by the Trustees pay UK Corporation Tax because their policy Where revenue is received in advance, are recognised in the SOFA in the year is to pay taxable profits to the Charity as Corporate sponsorship and products recognition is deferred and included in the grant is awarded and notified to the gift aid. Income from corporate sponsorship and creditors and where entitlement arises recipient, provided a legal or constructive products is measured at the fair value of before income is received, the income is commitment exists and any conditions Pensions consideration received or receivable and accrued. attaching to the grant have been fulfilled Employees are entitled to join the pension represents the amounts receivable, net of by the recipient. The liability is measured scheme provided by Aegon and Standard value added taxes. The Group recognises Grants as the total of expected payments for the Life. These are defined contribution revenue when it has an entitlement to Grant income, which is recorded within period to the next scientific review. schemes administered by an independent the revenue, it is probable that it will be income from charitable activities, is scheme administrators. Scheme funds are received and the amount can be reliably recognised when the funding offer is Costs relating to the sale of goods independent to the Charity and invested measured. Revenue from corporate communicated in writing to the Charity or include the direct costs of purchasing and with Aegon and Standard Life. The Charity sponsorship is recognised over the period of when performance related conditions are distributing goods for sale. contributes by matching employee the sponsorship arrangement. Revenue for met. contributions to their personal pension to the sale of goods is recognised at the point Communication and support costs are a maximum of 7% of salary. The cost of of sale. Furlough income reviewed and any costs directly relating providing this pension scheme is charged to Government grant income received from to our charitable activities have been the SOFA when it is incurred. Lotteries the Coronavirus Job Retention Scheme allocated to the appropriate strategic Income received in respect of lotteries is (‘Furlough income’) has been recognised charitable priority with the remainder being Investments recognised when the draw is made. Income on a receivable basis in the Statement of apportioned to charitable activities and Fixed asset investments are stated at fair received in advance for future lottery draws Financial Activities over the same period raising funds based on a combination of value at the balance sheet date. Any realised is deferred until the draw takes place. as the costs to which it relates. The headcount and staff time. or unrealised gains and losses are shown in government grant income is classified as the SOFA. Gains and losses are calculated The Charity receives proceeds of lotteries unrestricted. Governance costs are the costs incurred with reference to market values as at the held by the People’s Postcode Lottery to manage the Charity in compliance with beginning of the year or cost if purchased (‘PPL’). The Charity has no ability to alter Income from charitable activities constitutional and statutory requirements during the year. the price of tickets, determine the prizes or Income from charitable activities includes and are included in support costs. reduce the management fee. As such, PPL is income from intellectual property rights and Current investments are shown at cost less treated as acting as principal. Net proceeds is recognised on a receivable basis, Operating leases any provision for expected losses. due to the Charity are recognised under Rentals under operating leases are charged trading income in the SOFA. Expenditure on a straight-line basis over the lease term, Financial instruments Expenditure is accounted for on an accruals even if the payments are not made on such Basic financial instruments are initially Donated goods and services basis and attributed to the appropriate a basis. Benefits received and receivable as recognised at transaction value and Donated goods and services are recognised activities within the SOFA. an incentive to sign an operating lease are subsequently measured at amortised cost in the accounts when the benefit to the similarly spread on a straight-line basis over with the exception of investments which are Charity is reasonably quantifiable and Expenditure on raising funds includes the lease term. held at fair value. measurable. The value is the price the direct staff costs and expenditure relating Charity estimates it would pay should it to all fundraising activities. Support costs Taxation Financial assets held at amortised cost purchase equivalent goods or services. are apportioned on a headcount basis. Breast Cancer Care and Breast Cancer comprise cash at bank and in hand, together Additionally, it includes marketing costs and Now has charitable status and therefore with trade and other debtors excluding Investment income management support. any income and gains are exempt from prepayments. A specific provision is made Investment income is recognised on a corporation tax under Section 202 of the for debts for which recoverability is in receivable basis. Expenditure on charitable activities includes Corporation Act 2010 to the extent that they doubt. Cash at bank and in hand is defined direct staff costs and expenditure relating are applied for their charitable objects. as all cash held in instant access bank to charitable activities provision of services, accounts and used as working capital.

68 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 69 Financial statements and notes Financial statements and notes

Financial liabilities held at amortised cost Tangible assets are subject to an annual original sum invested. As at 7 April 2020, comprise all creditors excluding deferred impairment review, and any impairment the administrator’s estimate was updated income, social security and other taxes and identified is recognised in the SOFA in the to state that between 86.8% and 87.0% provisions. year of the review. will ultimately be recovered by the Charity. The Trustees have reduced the provision Assets and liabilities held in foreign currency Intangible assets to reflect the recovery in the year with a are translated to GBP at the balance sheet Intangible assets are stated at cost less carrying value of £Nil. The non-recovery date at an appropriate year end exchange accumulated amortisation. Intangible assets of the original sum invested is 13.33% or rate. of under £1,000 in value are not capitalised £583,000 (2019: 13.75% or £607,000). but are expensed fully in the year of No discounting has been applied to these purchase. In the view of the Trustees, no assumptions financial instruments on the basis that the concerning the future or estimation periods over which amounts will be settled Amortisation is calculated using the uncertainty affecting assets and liabilities are such that any discounting would be straight-line method at the following rate, at the balance sheet date are likely to result immaterial. calculated to write off assets over their in a material adjustment to their carrying estimated useful lives at the following amounts in the next financial year. Listed investments are included in the rate: balance sheet at fair value which is their Critical accounting judgements: closing bid price. Unlisted investments IT software and website: over 4 years *Donated goods and services are not are included in the balance sheet at their recognised where the incremental benefit fair value. Investments in subsidiary Critical accounting judgements and key to the Charity cannot be reliably measured. undertakings are held at cost less sources of estimation uncertainty This will primarily relate to services which impairment. All investment gains and losses In the application of the Group’s accounting are gifted on a pro-bono basis and there is are included within the SOFA. policies, Trustees are required to make no comparable expenditure incurred by the judgements, estimates and assumptions Charity. Please see note 2. At the balance sheet date the Group held about the carrying values of assets and financial assets at amortised cost of liabilities that are not readily apparent *Since the Charity is a charitable company, £28,439k (2019: £23,189k), financial assets from other sources. The estimates and it is subject to the restriction in the at fair value through income or expenditure underlying assumptions are based on Companies Act Accounts Regulations that of £8,522k (2019: £15,279k) and financial historical experience and other factors that prohibits the recognition of unrealised gains liabilities at amortised cost of £19,093k are considered to be relevant. Actual results in the profit and loss account. On acquisition (2019: £22,573k). may differ from these estimates. of Breast Cancer Care on 31 March 2019, the fair value of the assets received exceeded Tangible assets Critical accounting estimates: the fair value of the liabilities assumed. As Tangible fixed assets are stated at cost, less *Legacies inherently contain a degree of such, only the element of the gain which depreciation. Assets of under £1,000 in value uncertainty and are recognised in line with related to the realised profits can be are not capitalised but are taken fully as the income accounting policy. recognised as ‘Other income’ in the SOFA. expenditure in the year of purchase. The element of the gain which related to *KSF provision is calculated based on unrealised profits has been recognised as Disposed assets are removed from the the most recent progress report from ‘Other recognised gains’ in the SOFA. fixed asset register on the date of their sale the Administrators. At 1 August 2008, the or disposal. Any gain or loss on disposal Charity held £4,370,000 of short-term In order to make this assessment, the is included within the SOFA. Depreciation cash deposits with Kaupthing Singer and Charity has determined which of the assets is provided by the straight-line method, Friedlander (KSF). A further £44,000 was received were ‘qualifying assets’ within calculated to write off assets over their due in interest as at that date. On 8 October the meaning of company law. This involves estimated useful lives at the following 2008, the FSA applied to the High Court judgement. The Charity has a realised profit rates: for KSF to be put into administration, as only to the extent that the fair value of all they concluded that it no longer met the of the ‘qualifying assets’ received exceeded Fixtures and fittings: over 4 years FSA’s threshold conditions. The Charity the fair value of all of the liabilities taken Leasehold improvements: over lease period recovered £23,000 during the period, on. IT hardware: over 4 years taking the total recovery to 31 July 2020 to £3,825,000. This represents 87.5% of the

70 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 71 Financial statements and notes Financial statements and notes

2. DONATIONS AND LEGACIES 5. EXPENDITURE ON CHARITABLE ACTIVITES

Unrestricted Restricted 2020 Unrestricted Restricted 2019 Direct Support Total Direct Support Total £000 £000 £000 £000 £000 £000 Grants costs costs 2020 Grants costs costs 2019 £000 £000 £000 £000 £000 £000 £000 £000

Trusts and appeals 499 630 1,129 - 543 543 5a. Charitable activities Donations and legacies from individuals 15,046 3,018 18,064 14,099 1,409 15,508 Research 11,469 1,948 1,194 14,611 14,178 1,623 683 16,484 Corporate donations 3,037 168 3,205 4,289 1,117 5,406 Clinical - 879 372 1,251 - 413 213 626 Other income 604 - 604 - - - Services - 2,906 898 3,804 - 1,191 513 1,704 Total 19,186 3,816 23,002 18,388 3,069 21,457 Health Information & Policy - 2,265 688 2,953 - 2,182 394 2,576 Total 11,469 7,998 3,152 22,619 14,178 5,409 1,803 21,390 The Charit y benefits from the ser vices of unpaid volunteers. The value of this has not been recognised in the financial statements. Donations and legacies from individuals includes £129,144 (2019: £274,099) of donated goods for auction prizes. 5b. Grants 2020 2019 Of fice space of £Nil (2019: £3,000) was donated of which £Nil (2019: £Nil) would have other wise been purchased. Legal Grants were made to the following institutions during the year: £000 £000 advice was provided on a pro-bono basis the value of which totalled £94,000 (2019: £Nil) and has been recognised in the SOFA. During the year the Charity was donated advertising space the value of which was £97,000 (2019 £Nil) which has also been Institure of Cancer Research 6,656 7,943 recognised in the SOFA. The net amounts for pecuniary and residuary cases not included in legacy income as at 31 July 2020, Queen Mary University of London 1,015 594 but which are classed as a contingent asset total £29,000 (2019: £31,000). King’s College London 847 1,230 Royal College of Surgeons in Ireland 664 - Beatson Institute of Cancer Research 600 - 3. INCOME FROM OTHER TRADING ACTIVITIES University of Manchester 330 230 University of Birmingham 230 - University of Cardiff 230 230 Unrestricted Restricted 2020 Unrestricted Restricted 2019 University of Leeds 219 - £000 £000 £000 £000 £000 £000 University Medical Centre Utrecht, USA - 506 University of Glasgow - 460 Events 699 - 699 274 - 274 University of Liege, France - 398 Corporate products and sponsorship 2,816 481 3,297 3,318 853 4,171 Erasmus University Medical Centre - 363 Lottery income (note 27) 5,027 - 5,027 - - - Vall d’Hebron Institute of Oncology - 323 Other income 471 - 471 2,510 - 2,510 IDIBAPS - 275 Total 9,013 481 9,494 6,102 853 6,955 Catholic University of the Sacred Heart - 266 University of Edinburgh - 238 University of Dundee - 220 Imperial College London - 136 4. EXPENDITURE ON RAISING FUNDS Other Institutions 678 766 Total 11,469 14,178

Direct Support Total Direct Support Total costs costs 2020 costs costs 2019 £000 £000 £000 £000 £000 £000

Cost of raising funds from donations 13,209 2,980 16,189 14,590 2,980 17,570 and legacies Cost of other trading activities 647 148 795 549 102 651 Cost of managing investments 48 - 48 71 - 71 Total 13,904 3,128 17,032 15,210 3,082 18,292

72 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 73 Financial statements and notes Financial statements and notes

6. SUPPORT COSTS 8. EMPLOYEES (CONTINUED)

2020 2019 2020 2019 £000 £000 no. no.

IT, Finance & HR 2,904 1,396 The average number of employees during the year were: Office 2,131 2,077 Charitable activities 139 81 Management 712 785 Fundraising 138 110 Governance 533 627 Support Services and governance 34 34 Total 6,280 4,885 Total 311 225

Total support costs of £6,280,000 (2019:£4,885,000) comprise of charitable support costs of £3,152,000 (2019: £1,803,000) 2020 2019 and expenditure on raising funds of £3,128,000 (2019: £3,082,000). All support costs have been allocated entirely on a Total Total headcount basis. no. no.

The number of employees receiving remuneration over £60,000 (excluding employer pension contributions) during the year was as follows: £60,001 - £70,000 6 5 7. NET EXPENDITURE FOR THE YEAR £70,001 - £80,000 5 3 £80,001 - £90,000 1 1 £90,001 - £100,000 1 1 2020 2019 £000 £000 £100,001 - £110,000 1 2 £110,001 - £120,000 - - This is stated after charging: £120,001 - £130,000 1 - Depreciation and amortisation 615 450 £130,001 - £140,000 2 1 Auditors’ remuneration: Total 17 13 Audit work 76 59

Other services - taxation 6 4 Pension costs for these higher paid employees amounted to £132,016 (2019: £71,719). Operating leases rentals: Property 1,141 718 The key management personnel of the Charity comprise the Trustees, the Chief Executive, the Director of Corporate Services, the Equipment 23 42 Director of Communications & Influencing, the Director of Research, the Director of Services, Director Clinical Services and the Director of Fundraising. The total earnings, including pension contributions, received by the key management personnel of the Charity during the year were £824,059 (2019: £738,074). As part of the restructuring due to the coronavirus pandemic, two directors were made redundant and termination payments which totalled £124,431 are included in these costs. In 2019–20, the Chief Executive was the highest paid member of staff and received remuneration of £122,378 (the assessment as to the highest paid member of staff in the year excluded any 8. EMPLOYEES termination benefits paid).

Trustees have not received remuneration (2109: £Nil). Trustees have been reimbursed expenses incurred in undertaking their duties as 2020 2019 disclosed in note 22. £000 £000

Wages and salaries 12,181 8,414 Social security cost 1,148 829 Pension costs 856 446 Other employee benefits 26 20 Total 14,211 9,709

Termination payments during the year totalled £589,000 (2019: £188,000). Termination payments are recognised on an accruals basis and are included in wages and salaries.

74 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 75 Financial statements and notes Financial statements and notes

9. INTANGIBLE ASSETS (GROUP AND CHARITY) 11. INVESTMENTS (GROUP AND CHARITY)

IT Software 2020 2019 & Website £000 £000 £000

Cost Market value at 1 August 15,279 15,727 At 1 August 2019 1,279 Realised gains 8 (36) Additions 467 Unrealised (losses)/gains (649) 842 Disposals (867) Income reinvested 130 174 At 31 July 2020 879 Business combination (note 24) - 4,174 Investment fees (48) (35) Accumulated amortisation Withdrawals (6,198) (5,567) At 1 August 2019 906 Market value at 31 July 8,522 15,279 Charge for the year 159 Disposals (829) All investment assets are held in the UK and are unrestricted. The total historic cost of these investments is £3,176,000. The holdings by fund on a market value basis are as follows: At 31 July 2020 236

2020 2019 Net book value £000 £000 Brought forward at 1 August 2019 373 Carried forward at 31 July 2020 643 Fund Asset class Fund manager Charishare Equities BlackRock 3,946 4,525 CCLA Equities, fixed interest and cash CCLA 4,576 4,564 Goldman Sachs Equity linked Goldman Sachs - 6,190 10. TANGIBLE ASSETS (GROUP AND CHARITY) Total market value 8,522 15,279

Leasehold Fixtures and IT Improvements Fittings Hardware Total £000 £000 £000 £000 12. CURRENT INVESTMENTS (GROUP AND CHARITY)

Cost At 1 August 2019 1,147 357 942 2,446 2020 2019 £000 £000 Additions 2 - 46 48 Disposals (39) (21) (176) (236) At 31 July 2020 1,110 336 812 2,258 Balance as at 1 August 4 32 Write back of provision 19 - Accumulated depreciation Transfer to cash at bank and in hand (23) (28) At 1 August 2019 403 133 492 1,028 Balance as at 31 July - 4 Charge for the year 143 99 214 456 Disposals (40) (21) (165) (226) The provision has been reduced to reflect a carrying value of £Nil given the dividends received in the year. An assessment At 31 July 2020 506 211 541 1,258 of the provision is set out in the critical accounting estimates in note 1.

Net book value Carried forward at 31 July 2019 744 224 450 1,418 Carried forward at 31 July 2020 604 125 271 1,000

There were no assets held under finance leases in either year.

76 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 77 Financial statements and notes Financial statements and notes

13. SUBSIDIARY UNDERTAKINGS 15. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Breast Cancer Now has three active subsidiaries; BCN Trading Ltd (03090884), BCN Research Ltd (05047652) and Breast Group Group Charity Charity Cancer Care Trading Ltd (02681072). The Charity also has 5 dormant subsidiaries and 1 non-trading subsidiary. All of the 2020 2019 2020 2019 subsidiaries are incorporated in the United Kingdom and have a year end of 31 July, with the exception of Pink Ribbon Ltd. £000 £000 £000 £000 The investment in subsidiary undertakings held by the Charity at 31 July 2020 was £245 (2019: £245). Trade creditors 218 1,787 210 1,321 Grants payable 10,442 11,964 7,635 8,739 Breast Breast Cancer Cancer Care Now Research Second BCN BCN 2020 2019 Taxes and social security 1,425 746 1,425 745 Trading Ltd Lotteries Ltd Hope Research Ltd Trading Ltd Total Total Accruals and deferred income 3,707 2,918 1,499 1,777 £000 £000 £000 £000 £000 £000 £000 Other creditors 129 386 122 384 Total 15,921 17,801 10,891 12,966 Turnover 559 - - 39 3,209 3,807 6,646

Cost of sales (13) - - (38) (17) (68) (2,421) Deferred income comprises sponsorship income received in advance of fundraising events taking place in 2020-21, as well Interest receivable - - - 35 - 35 56 as income received in advance for entries to our weekly lottery. Deferred income also includes income received relating to Administrative expenses (62) - - (36) (534) (632) (503) the Catalyst Programme which is run through BCN Research Ltd, a wholly owned subsidiary of Breast Cancer Now. Income is Profit before gift aid and taxation 484 - - - 2,658 3,142 3,778 recognised at the point research spend is committed. Gift Aid payable to the Charity (484) - - - (2,658) (3,142) (3,216) Profit before taxation ------562 Deferred income Group Group Charity Charity Tax expense ------2020 2019 2020 2019 Profit after taxation ------562 £000 £000 £000 £000

Balance as at 1 August 1,849 357 784 295 Assets 1,421 9 163 2,912 3,559 8,064 12,297 Amount released to income (1,849) (357) (784) (295) Liabilities (1,421) - - (2,912) (3,552) (7,885) (11,719) Amount deferred in year 2,442 1,849 240 784 Net assets - 9 163 - 7 179 578 Balance as at 31 July 2,442 1,849 240 784

Breast Cancer Campaign (05074725), Breakthrough Breast Cancer (02848982), Pink Ribbon Ltd (04690589), Breast Cancer Care (02447182) and Breast Cancer Now Support and Care Lotteries Ltd (12397737) are dormant companies. On 30 April the Charity became the Sole Trustee of Second Hope a registered charity (No: 1163205). Breast Cancer Now Research Lotteries Limited (03239583), formerly Breakthrough Promotions Limited, has taken advantage of the small company audit exemption for 2019–20. The taxable profit from the subsidiaries each year is transferred to the parent Charity as a Gift Aid payment. For 16. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR 2019–20 a total payable of £3,142,000 to the parent Charity has been recognised in addition to £562,000 from Breast Cancer Care Trading Limited relating to the four month period to 31 July 2019. For a full listing of the subsidiary undertakings please Group Group Charity Charity see note 26. 2020 2019 2020 2019 £000 £000 £000 £000

Grants payable 7,039 6,864 4,127 3,095 14. DEBTORS

Group Group Charity Charity 2020 2019 2020 2019 £000 £000 £000 £000

Trade debtors 672 3,690 379 2,524 Amount owed by subsidiary undertakings - - 3,625 3,117 Other debtors 107 518 107 514 Prepayments & accrued income 6,533 8,339 5,680 5,596 Total 7,312 12,547 9,791 11,751

Trade debtors includes £Nil (2019: £Nil) falling due after more than one year. Trade debtors are stated after provisions for impairment of £6,000 (2019: £29,000). Amounts owed by group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.

78 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 79 Financial statements and notes Financial statements and notes

17. GRANTS PAYABLE 19. RECONCILIATION OF FUNDS

2020 2019 Balance at Investment Balance at £000 £000 1 August 2019 Income Expenditure losses 31 July 2020 £000 £000 £000 £000 £000 At 1 August 18,828 18,506 Awarded during the year 13,141 14,842 Unrestricted funds 15,094 35,740 (36,376) (641) 13,817 Paid during the year (12,816) (13,856) Restricted Adjustments during the year (1,672) (664) Tissue Bank (1) - 31 (31) - - As at 31 July 17,481 18,828 Prevention Research (2) 669 912 (1,206) - 375 Kings College London (3) - 43 (43) - - Due within one year (note 15) 10,442 11,964 Molecular Cell Biology (4) - 450 (450) - - Due after one year (note 16) 7,039 6,864 Gene Function Analysis (5) - 30 (30) - - As at 31 July 17,481 18,828 Secondary Research (6) 550 498 (100) - 948 Other restricted funds (7) 42 2,333 (1,415) - 960 A list of all grants awarded in year is included under Note 5b which represents grants awarded during the year of £13,141,000 Total restricted funds 1,261 4,297 (3,275) - 2,283 and adjustments during the year of £(1,672,000), totalling £11,469,000. Adjustments during the year of £1,672,000 (2019: £664,000) reflect research grant award underspend which has arisen due to Covid-19 restrictions in the year. Total Group funds 16,355 40,037 (39,651) (641) 16,100

At 31 July 2020, the Charity had unrecognised commitments of £54.8m (2019: £64.2m) for grant awards which are conditional upon the favourable outcome of both scientific and financial reviews. The decrease reflects the impact of the Unrestricted Charity funds 14,517 35,985 (36,057) (641) 13,804 grants awarded in the year. The contingent liability relates to grants which are expected to be awarded until the next grant Restricted Charity funds 1,261 4,297 (3,275) - 2,283 process in 2024-25. These commitments will be funded from income in the relevant period. Total charity funds 15,778 40,282 (39,332) (641) 16,087

Notes (1) Donations specifically given to fund the Breast Cancer Now Tissue Bank (2) Donations specifically given to fund the research area of prevention 18. PROVISIONS FOR LIABILITIES (GROUP AND CHARITY) (3) Donations specifically to suppor t the research unit at Kings College London (4) Donations specifically to suppor t the Molecul ar Cell Biology Team at the Institute of Cancer Research (5) Donations specifically to support the Gene Function Analysis at the Institute of Cancer Research Onerous lease Dilapidations Total Onerous lease Dilapidations Total (6) Donations specifically to suppor t the research area of secondar y breast cancer 2019 2020 2020 2019 2019 2019 (7) This includes a variety of funds, where donations are restricted to specific areas of research and other charitable £000 £000 £000 £000 £000 £000 activity.

Balance as at 1 August 395 258 653 - - - Business Combination - - - 557 - 557 Additional provision 262 83 345 - 258 258 Utilised (481) - (481) (162) - (162) Release ------Balance as at 31 July 176 341 517 395 258 653

The onerous lease is expected to be utilised by November 2021 and the dilapidations provision is expected to be utilised by January 2025.

80 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 81 Financial statements and notes Financial statements and notes

20. ANALYSIS OF NET ASSETS BETWEEN FUNDS 22. TRUSTEE EXPENSES

Group Group Group Group Group Group The Trustees received no remuneration in the year. Four Trustees received reimbursement for travel and accommodation Unrestricted Restricted Total Unrestricted Restricted Total expenses totalling £1,709 for the year (2019: £1,786). The Charity has in place insurance to indemnify the Trustees for 2020 2020 2020 2019 2019 2019 actions brought against them for wrongful acts committed. A Trustee indemnity insurance policy was held during the year £000 £000 £000 £000 £000 £000 as follows:

Tangible & intangible assets 1,643 - 1,643 1,791 - 1,791 From 1 April 2019 to 31 March 2020 - Hiscox Ltd. Indemnity cover of £2,000,000. The cost of this specific policy is £1,022. Investments 8,522 - 8,522 15,279 - 15,279 From 1 April 2020 to 31 March 2021 - Hiscox Ltd. Indemnity cover of £2,000,000. The cost of this specific policy is £1,159. Net current assets 11,208 2,283 13,491 5,541 1,261 6,802 Long term liabilities (7,556) - (7,556) (7,517) - (7,517) Total net assets 13,817 2,283 16,100 15,094 1,261 16,355 23. RELATED PARTY DISCLOSURES Charity Charity Charity Charity Charity Charity Unrestricted Restricted Total Unrestricted Restricted Total In accordance with FRS 102, the Charity discloses related party transactions that were recognised in the SOFA. Expenses 2020 2020 2020 2019 2019 2019 reimbursed to Trustees are disclosed in Note 22 of the financial statements. Remuneration of key management personnel is £000 £000 £000 £000 £000 £000 disclosed under Note 8 of the financial statements.

Tangible & intangible assets 1,643 - 1,643 1,791 - 1,791 However, some Trustees, members of the Charity’s Board and directors of its subsidiary undertakings are Trustees or Investments 8,522 - 8,522 15,279 - 15,279 directors of organisations that are in receipt of funds from the Group or enter into commercial transactions with the Group. Net current assets 8,283 2,283 10,566 1,195 1,261 2,456 The following transactions are disclosed as the individuals concerned are regarded as holding a position of influence in both Long term liabilities (4,644) - (4,644) (3,748) - (3,748) parties to the transactions concerned at the time they were entered into: Total net assets 13,804 2,283 16,087 14,517 1,261 15,778 • The parent Charity received income of £3,814,000 (2019: £3,225,000) from Asda Tickled Pink during the year and had an outstanding debtor of £Nil at year end (2019: £11,000). The Chief Executive, Baroness Delyth Morgan, holds the position of Trustee at Asda Tickled Pink.

• During the year the Charity awarded grants of £199,000 (2019: £Nil) to the University of Oxford and had an outstanding 21. FINANCIAL AND OTHER COMMITMENTS creditor of £358,000 at year end (2019: £263,000). The Charity made a payment of £105,000 during the year (2019:£181,000). Trustee Professor Adrian Harris is Professor of Medical Oncology at the University of Oxford. Operating lease commitments The Group and Charity have the following future minimum lease payments under non-cancellable operating leases for each • During the year the Charity awarded grants of £Nil (2019: £230,000) and grant adjustments of £6,000 (2019: £Nil) to the of the following periods: University of Edinburgh and had an outstanding creditor of £328,000 at year end (2019: £433,000). The Charity made a payment of £99,000 during the year (2019:£181,000). Trustee Mark Astaire, who was appointed as a Trustee on 1 April 2019 2020 2019 is a member of the International Advisory Board of the University of Edinburgh. £000 £000 • The Charity paid for membership and conference related costs to the National Cancer Research Institute (NCRI) totalling Property leases expiring: £40,000 (2019: £46,000) during the year. In addition, the Charity awarded a grant to NCRI of £Nil (2019: £Nil) and had an Within one year 953 956 outstanding creditor of £2,500 at year end (2019: £5,000). The Charity made a payment of £2,500 during the year (2019: Within two to five years 3,216 4,230 £2,500). The Chief Executive, Baroness Delyth Morgan, holds the position of Director at the NCRI. In over five years - 321 During the year, the Charity had the following transactions with its subsidiary companies: Equipment leases expiring:

Within one year 2 2 • Payable under Gift Aid from BCN Trading Ltd of £2,658,000 (2019: £3,126,000) and management charge of £523,000 (2019: Within two to five years - - £406,000). In over five years - - • Payable under Gift Aid from BCN Research Ltd of £Nil (2019: £90,000). Lease payments expensed in the year are disclosed in note 7. • Payable under Gift Aid from Breast Cancer Care Trading of £1,046,000 (2019:£Nil) and management charge of £49,000 (2019: £69,000).

At the year end, the Charity had an outstanding debtor balance due from BCN Trading Limited of £2,202,000 (2019: £2,569,000), an outstanding debtor balance due from BCN Research Limited of £9,000 (2019: £98,000), and an outstanding debtor balance from Breast Cancer Care Trading Limited of £1,414,000 (2019: £451,000).

82 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 83 Financial statements and notes Financial statements and notes

24. OTHER INCOME 26. SUBSIDIARY ENTITIES

On 31 March 2019, Breast Cancer Now (‘BCN’) acquired all the assets and liabilities of Breast Cancer Care (‘BCC’) under a Name % Registration Registered office Status Transfer Agreement. Prior to the acquit ion BCN’s focus was on research and policy and campaigning for breast cancer. BCN Trading Limited 100 England & Wales Fifth Floor, Ibex House, Trading As a result of the acquisition the Group has broadened to cover care and support for those suffering from breast cancer 42-47 Minories, London EC3N 1DY and secondary breast cancer. The acquisition also provides greater geographical reach through the ‘centres of excellence’ BCN Research Limited 100 England & Wales Fifth Floor, Ibex House, Trading operated by BCC. There was nil consideration for the acquisition. 42-47 Minories, London EC3N 1DY Breast Cancer Care 100 England & Wales Fifth Floor, Ibex House, Trading Following the acquisition BCC has not traded. Given the full integration of the BCC operations with Breast Cancer Now it Trading Limited 42-47 Minories, London EC3N 1DY is not possible to identify the income and expenditure of the acquired business in the period April to July 2019. Directly attributable costs of £106,000 have been incurred relating to the acquisition of BCC. The following table summarises the Breast Cancer Now 100 England & Wales Fifth Floor, Ibex House, Non-trading recognised assets of the identifiable assets acquired and liabilities assumed at the acquisition date. Research Lotteries Limited 42-47 Minories, London EC3N 1DY (formerly Breakthrough Note Book value Adjustments Fair value Promotions Limited) £000 £000 £000 Breast Cancer Care 100 England & Wales Fifth Floor, Ibex House, Dormant Tangible fixed assets A 771 (216) 555 42-47 Minories, London EC3N 1DY Investments 4,174 - 4,174 Pink Ribbon Limited 100 England & Wales Fifth Floor, Ibex House, Dormant Cash at bank and in hand 5,546 - 5,546 42-47 Minories, London EC3N 1DY Stock 56 - 56 Breast Cancer Campaign 100 England & Wales Fifth Floor, Ibex House, Dormant 42-47 Minories, London EC3N 1DY Debtors 3,860 - 3,860 Breakthrough Breast Cancer 100 England & Wales Fifth Floor, Ibex House, Dormant Creditors (1,687) - (1,687) 42-47 Minories, London EC3N 1DY Provisions for liabilities B (260) (297) (557) Breast Cancer Now Support 100 England & Wales Fifth Floor, Ibex House, Dormant Total net assets 12,460 (513) 11,947 and Care Lotteries Limited 42-47 Minories, London EC3N 1DY Cash consideration - Charitable Incorporated Ownership Regulator Registered Office Status Fair value of Gift 11,947 Organisation Second Hope Sole Charity Fifth Floor, Ibex House, Active Note Trustee Commission 42-47 Minories, London EC3N 1DY A A decrease in tangible fixed assets following an impairment review of assets acquired. A significant element of this relates to the leasehold improvements relating to the London office building previously used by the BCC Charity.

B An increase in provision for onerous leases and adjustment to dilapidations provision following a third party valuation. 27. PEOPLES POSTCODE LOTTERY (PPL) INCOME

The total value of the gift of £11,947,000 is analysed between qualifying consideration of £9,275,000 and non-qualifying consideration of £2,672,000. Lottery income includes income from PPL. The Charity received £639,126 of net proceeds from PPL during the year (2019: £Nil).

2020 2019 £000 £000 25. FURLOUGH INCOME Ticket value 1,997 - Prize fund (799) - During the year the Charity accounted for a receivable under the Government’s Job Retention Scheme of £1,686,000 (2019: £Nil). Management fee (559) - Net proceeds 639 -

84 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 85 Legal and administrative details Thank you

LEGAL AND ADMINISTRATIVE DETAILS THANK YOU For the year ended 31 July 2020

Patron Glasgow We thank all the breast cancer patients who have We thank the many hundreds of experts from across HRH The Prince of Wales Robertson House, kindly donated tissue and blood samples to our the world who have provided detailed feedback on Ground Floor, Tissue Bank. grant applications. Independent Auditors 152 Bath Street, PricewaterhouseCoopers LLP, Glasgow, G2 4TB We thank the members of the Grants Committee, the We thank everyone who took part in our Secondary 1 Embankment Place, Science Strategy Committee, Tissue Bank Advisory Breast Cancer Campaign Group, and remember London, WC2N 6RH Sheffield Council, Tissue Access Committee and the Catalyst those who have sadly passed away: St James House, Committee. (Correct at time the annual report and accounts was signed). Bankers Vicar Lane, Barclays Bank plc, Sheffield, S1 2EX We thank the staff and scientists in the laboratories Joy Knott 1 Churchill Place, we fund who have taken the time to show people Sarah Aiton (passed away) London, E14 5HP Cardiff around their labs and talk about the work Breast Rachel Sorensen 1st Floor, Cancer Now is funding. Rebecca Willcox (passed away) Solicitors 14 Cathedral Road, Flora Sheringham Russell Cooke, Cardiff, CF11 9LJ We thank the officers and members of the All- Judith Willowe 2 Putney Hill, Party Parliamentary Group on Breast Cancer, Joanne Myatt London, SW15 6AB [email protected] especially Co-Chairs Craig Tracey MP and Bambos Laura Ashurst breastcancernow.org Charalambous MP. Gina Carson Investment Managers Helen Barnes BlackRock Investment Managers, Research Centre Thanks to all Breast Cancer Now Ambassadors and Jen Hardy 12 Throgmorton Avenue, The Breast Cancer Now Toby Robins the MPs, MSPs and AMs who supported our work, Alison Tait London, EC2N 2DL Research Centre, tabled questions, met with their constituents, took Carolyn Gammon (passed away) Mary-Jean Mitchell Green Building, part in our wear it pink Parliamentary photocalls, and Tracey Williams (passed away) CCLA (from 1 April 2019), The Institute of Cancer Research, continue to help us raise awareness of breast cancer Nicola Ingram Senator House, London, SW3 6JB and highlight the issues faced by them. Melanie Kennedy (passed away) 85 Queen Victoria Street, Joanne Taylor London, EC4V 4ET Director: Professor Andrew Tutt We thank all the people affected by breast cancer Prabhjot Kaur who have shared their experiences to inform the Shakun Banfield Coutts & Co (until January 2019), appraisal of a number of breast cancer drugs. Miranda Ashitey 440 Strand, Aliya Hasan London, WC2R 0QS We thank all the facilitators, expert speakers and Shelley Lee healthcare professionals across the UK who have Constance Johncock Registered Office contributed their time, expertise and energy to Nathalie Wastie-Brett 5th Floor, making sure people with breast cancer have access Beth Roberts (passed away) Ibex House, to, and benefit from, our support services. Claire Myerson 42-47 Minories, Mary Huckle London, EC3N 1DY We thank our wonderful volunteers who give their Fiona Leslie (passed away) time freely to support others, raise awareness about Jane O’Neill Edinburgh (now closed) the work of the charity and join us in campaigning for 222/2 Leith Walk, better treatment and care. We thank all the healthcare professionals, patients Edinburgh, EH6 5EQ and volunteers who have helped make our Service We thank the many NHS hospitals across the UK Pledge work such a success, ensuring that patient who work with us in delivering our Moving Forward experience is continually improved across England. courses and host our Information Points.

86 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 87 Thank you Thank you

We thank the organisations and individuals who Barclays Bank part of Women v Cancer stylists have supported our public health and wellbeing Belinda Gray & Art For Cure Duncan Spence Hilton Glasgow work including Sport England, the Richmond Group Beverley Nash House of Fraser of Charities and Professor Annie Anderson of the BFT MastClimbing Ltd East Dunbartonshire & Glasgow Group ActWELL trial. easyJet Big Yellow Storage I Saw It First We thank every individual, local Breast Cancer Now Bishop’s Stortford - Gill Blair-Park & Annice Osborne EDF Energy Ian Barraclough group, £1k Challenger, RAG and charitable trust who Bognor Regis Golf Club Edinburgh Fundraising Group Ian Tod has donated or raised money for us in the past year Boobs and Brass Edith Murphy Foundation Isle of Man or remembered us in their Will. Breast Mates Stowmarket Group Elaine Mitchell Isle of Wight - Sarah Tyrrell-Jones Bromley Group - Lorraine Hathorn Eleanor Moffat Bromley Youth Music Trust ELEMIS James Auld & SAIF WE ALSO ACKNOWLEDGE THE Bruckhaus Deringer Eli Lilly James Holgate BT Ellen Kane Trust Jamie Godin GENEROUS SUPPORT OF Burgess Hill Breast Cancer Now Group Emma Barker Jan Hulme EP Barrus Jane Brooks 3Ts Charitable Trust Cameron Events Essex Fundraising Group - Sarah Gaeta Jane Smith Cardiff & Vale Group Estee Lauder Jane Woodward A Bigger Bounce Committee Careys Foundation Eversheds Sutherland Janet Brennand ACCA Carolyn Collard Eveson Charitable Trust Jason Guy Alex Ball Chantele Rashbrook and the Clifftop Challengers Joanne and Chris Thomson Alex Lloyd, Tour de Law Volunteer Cherie Blair Fairfax And Favor John Hartson Foundation Amanda Jones Cheshire Fundraising Group Falmouth Breast Cancer Now Group John Lewis Amgen Chris Sturgess and The Show London Committee Fighting Breast Cancer Herts June McCullough Angela Quinn Chris Ttoffali Flintshire Fundraising Group Anglian Water Christopher and Lynn Hammersley Flowers by Post Katie Hammond Ann Summers Claire Seedhouse Fortnum & Mason Kerry Banks BME Anna Stevenson Clive, Jack and Lucy Ellis Frank Adams, Jane Davalle and Beryl Smallpeice King & Spalding LLP Asda Colin Wilmott, Rhian Owen and Kate Wilmott-Smith Freshfields Ashley Wilton Cotswold Breast Cancer Now Group Garfield Weston Foundation L’Inviti Singers Curves Gyms George Lakeside Leisure Group Asda suppliers taking part in Tickled Pink: George Darby, Nina Caplin and Leigh Jenkins Latham & Watkins LLP Bonnier Books UK D&D London ghd Linda Dye Cereal Partners – Nestlé and General Mills Damart Glasgow Fundraising Group Linda Larter MBE, Chief Executive Sevenoaks Town Coca Cola European Enterprises David Chappell Glasgow High Kelvinside RFC Council Kellogg’s David Guest Goodbox Linda Lee Lindt & Sprungli David Phillips Greenberg Liz Mackay Mondelez UK David Watkins Gregg Drennan London Wembley BCN Group Nestle UK Dawsongroup Gregory Stone Lorraine Hathorn Penguin DCW Group Guillaume Soumier Lulu Guinness Premier Foods Delicious magazine Lynn Dewar P&G DHL Air Haley Family Charitable Trust Unilever Doris Field Charitable Trust Hallmark M&S SC Johnson Dorothy Perkins Hasan Hejazi Limited Mad March Hare Transworld Dorset Breast Cancer Now Group Hayley Carpenter-Priest Maltin PR Twinings Dream Challenges for their continued support as Hilary Alexander, Deborah Britz and the team of Margaret Davies Weetabix

88 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 89 Thank you Thank you

Mark and Claire Urquhart Martim Valente Sally-Ann Petts Mary Carmichael Samantha Lipman Mary-Jean Mitchell Green Foundation Santander Matthew Parsons Saracens Sport Foundation Members of the Care Collective Sassoon Mike Phillips Shayne Taylor Milk_Shake Haircare Sheila McNicol Monica Vinader Sheila Wilson Moondance Foundation Simon Halden (Sarah Greene Tribute Fund) Skechers N Brown SLX Nan McDonald Sofology National Lottery Community Fund Somerset Breast Cancer Now Group Neath Group Southside Ladies Fundraising Group New Romney Group - Hayley CP St Paul’s Knightsbridge Nick Capehorn at Theme Staffordshire Fundraising Group Nick Payne Steph Harrison for her continued Sevenoaks Pink Novartis Week and community fundraising Surrey Group - Katie Baker Oldmeldrum Fundraising Group SweetSpot for their continued partnership for The One Stop Women’s Tour

Palmers The Berkeley Pam Penfold The Show Scotland Committee Park Plaza Westminster Bridge Think Pink York Fundraising Group Pentel Tikiboo Perth Racecourse Trendsetter Pfizer Trisha Davidson Philip Small Turnhouse Golf Club (Maggie Pringle) Philippa Lovering Pink on the Tyne Fundraising Group Val McGavin Pink Ribbon Ball Committee Valerie Stephenson Players of People’s Postcode Lottery Polly and Wayne Barnes Wales Fundraising Committee & Nick Young Premier Paper Walk the Walk Worldwide West Ham United Womens Football Team Rachel Ireland West Midlands Fundraising Group Redlibbets Golf Club Wilkie Farr & Gallagher LLP River Island William Grant Foundation Robert Cuthbertson Wright Hassall LLP Robin Lancashire, Sharon Smits and Liz Franklin Roche Zochonis Charitable Trust Rosemary Walker Rugby Against Cancer/Aaron Beesley

90 Annual Report and Accounts 2019–20 Annual Report and Accounts 2019–20 91 Breast Cancer Now is a charity registered in England and Wales (1160558) and Scotland (SC045584), 92 and a business name of theAnnual registered Report charity and in theAccounts Isle of Man 2019–20 (1200).